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Microbial communities play a vital role in shaping their local environment and 
provide many important ecosystem services. The structure and function of 
microbial communities is dependent on interactions with prokaryote-specific 
viruses and other mobile genetic elements (MGEs), but we know relatively little 
about these interactions in nature. The prokaryotic adaptive immune system 
CRISPR-Cas provides resistance to phage and other MGEs by inserting phage-
derived sequences into CRISPR loci on the host genome to allow sequence 
specific immunological memory against re-infection. Compared to the specific 
mechanism of CRISPR-Cas, phage resistance via surface modification provides 
general defense against a range of phage by physically modifying the cell surface 
to prevent phage infection. CRISPR-Cas and surface modification have been 
shown to be the most common mechanisms for rapid evolution of de novo phage 
resistance and therefore likely play important roles in shaping microbial 
communities. It has been suggested that we may be able to manipulate CRISPR-
Cas evolution to our advantage, but very little research has been done 
investigating the evolutionary outcome of such manipulation. In this thesis I 
investigate the importance of different ecological drivers on when CRISPR-Cas 
is favoured over phage resistance via surface modification. I find that increasing 
CRISPR allele diversity within a host population increases phage immunity at the 
population level. However, increasing genetic diversity within the phage 
population increases selection for generalist phage defence via surface 
modification over specific CRISPR-Cas resistance. I also attempt to investigate 
the importance of cell-cell communication in the evolution of bacterial resistance; 
however these experiments were hampered by secondary effects of inhibiting 
cell-cell communication. These results are discussed in context with recent 
findings with the aim of expanding our knowledge of CRISPR-Cas evolution and 
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The importance of microbial communities 
Microbial communities play a vital role in shaping their local environment and 
provide many important ecosystem services including the breaking down of 
pollutants, municipal waste and ingested food, and the recycling of organic matter 
to plants and other autotrophs (1). These services are often essential to the health 
of the ecosystem: Microbial community health has been shown to be linked to the 
health and survival of associated organisms and therefore there are cascading 
effects of disturbance of natural microbial community dynamics. With recent rapid 
advances in ‘omics’ techniques and technologies we are now able to analyse 
microbes and their communities in more detail than ever before advancing a wide 
range of fields of microbial study (1–6). Microbial community health and dynamics 
have been shown to be important in many ecological processes, for example, 
plant-associated microbes trigger essential functions in plants such as 
germination, growth, disease defence, stress resistance, and influence plant 
fitness with microbial dysbiosis correlating with disease prevalence (7, 8). Insect 
population health has also been shown to be dependent on a healthy microbiome 
(9), and in aquatic environments microbes are known to be fundamental to 
biogeochemical cycles, the disruption of which has been suggested to have 
negative global effects (10, 11). In humans it has been found that early life 
exposure to microbes is a key determinant of gut microbiota diversity throughout 
the individual’s life. Studies have shown that humans living in Western cultures 
where exposure to diverse microbial populations is reduced due to the effects of 
urbanisation and agriculture have decreased gut microbiota diversity (12, 13). 
This has been linked with an increase in inflammatory bowel disease, diabetes, 
obesity, allergies and asthma (13, 14), which has led to the suggestion that soil 
biodiversity loss could pose public health threat (13).  
Studies focusing on microbial community dynamics and health are revealing that 
many human activities have a drastic and long-lasting impact. For example crop 
production has been shown to alter microbial communities in soil for years after 
the land is no longer used, even when varying crop rotations were implemented, 
which we now understand may represent irreparable damage to the associated 
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ecosystem (15). This may be partly due to the majority of microbial diversity being 
found in the top layers of soil (16) which is frequently and radically disturbed by 
any agricultural activity. Furthermore, we have found that we have been 
inadvertently imposing selective pressures on microbial communities through 
activities such as antibiotic and pesticide treatment which have resulted in 
undesirable changes in local microbial communities in agricultural and clinical 
settings. These changes include introducing antibiotic (17–19) and pesticide 
resistance (20, 21) which are strong contributing factors to major global health 
concerns (17).  
In addition to their importance in nature, many industrial processes rely on 
microbes. For example yoghurt and cheese production typically involve the use 
of “starter strains” of bacteria such as Streptococcus thermophilus and 
Lactobacillus delbrueckii subsp. bulgaricus, which are added to milk where 
natural bacterial activity converts the lactose sugar found in milk to lactic acid (22, 
23). Spores of the bacterium Bacillus thuringiensis are produced in vats, known 
as bioreactors, via fermentation. B. thuringiensis spores are the active agent in 
more than 50% of microbial control agents sold as they are relatively cheap and 
easy to apply (24). Different subspecies of B. thuringiensis are effective against 
a range of species including within the orders of Lepidoptera, Diptera, and 
Coleoptera and some pest nematode species (25–27). The ability to target 
different pest species allows for organic targeted pest control, minimising harm 
to the surrounding environment and allowing for more responsible and 
sustainable pest control (28–30). Further research into microbial interactions will 
allow for advances in practice and policy in industry which minimise product loss 
and reduce the cost of these products. 
 
Bacteria-phage interactions influence microbial communities 
Bacteria-phage interactions are significant because they play a major role in 
shaping microbial communities (31, 32). Bacterial populations which are 
currently, or have recently had contact with phage usually undergo genomic 
changes as a result of bacteria-phage interactions (33). The key processes of 
bacteria-phage interactions are the ability of phage to infect hosts and the ability 
of bacteria to defend themselves from phage infection. Both phage and bacteria 
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are known to evolve different mechanisms of infectivity and resistance, 
respectively, with different traits being favoured in differing ecological settings 
(34–37). Co-evolution between phage and bacterial populations has been found 
to be associated with strong selective pressures, resulting in drastically altered 
phenotypes evolving in both bacteria and phage populations when compared with 
the ancestral populations (33). Therefore understanding bacteria-phage 
dynamics will allow us greater insight into how to predict evolutionary outcomes 
with many potential applications including vaccine development (38), ecosystem 
analysis (39), co-evolution studies (40), infection prevention in microbial industrial 
applications (41), phage based medical and industrial treatments and 
environmental prophylaxis (42). 
Phage infection can have dramatic effects on bacterial host population genomes 
(32, 37, 43, 44). Phage infection can select for genome wide evolution in bacterial 
hosts (45) as well as direct phage-mediated transfer of genes between host cells 
(46, 47). Common mutations acquired by bacteria as a result of contact with 
phage include reduced expression of genes involved in type IV pilus (T4P) and 
lipopolysaccharide (LPS) biosynthesis (48). Reduced T4P and LPS production 
infers resistance to a range of phage by interfering with phage adsorption, 
however mutations in these regions are associated with a fitness cost in the 
absence of phage (48). The T4P is known to act as a receptor for conjugation 
which has been shown to be an important mechanism in the horizontal transfer 
of pathogenicity islands (49) while lipopolysaccharide production is associated 
with virulence and biofilm formation (50–52). Therefore controlled phage infection 
presents an opportunity to manipulate bacterial populations to our advantage, 
reducing or selecting against the spread of pathogenicity and virulence traits, 
however detailed understanding of the evolutionary outcomes of specific 
bacteria-phage interactions is required before these practices can be applied on 
a large scale.  
The antibiotic crisis underlines the importance of understanding microbes and 
how their evolution may impact us and is driving a wealth of research into 
alternative treatments (42, 53–55). Hospitals are known to be sources of 
microbial diversity and our search for ways to treat multi drug resistant strains 
has led to the resurrection of research into phage therapy (42). During phage 
therapy a patient with a bacterial infection is treated with phage which infect the 
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virulent bacterial species, thereby eradicating the virulent bacteria without the use 
of antibiotics. There have been promising trials and reports of using phage-based 
treatments for bacterial infections (56–60), however phage therapy is not 
standardly available yet, a lack of knowledge of microbial interactions may 
prevent the advancement of this treatment since tailoring the phage “cocktail” 
correctly to each patient is vital (42).  
Phage based treatments could also help reduce losses in industrial production 
processes such as bioreactors incubating the bacterium B. thuringiensis to phage 
infection (61) or vats fermenting dairy products which rely on bacterial activity 
(41). These processes are highly vulnerable to phage infection as they require 
the creation of high densities of bacteria (41, 62) so phage infection can lead to 
huge losses, increasing the prices of products. This has led to the suggestion of 
manipulating the bacteria to infer phage resistance however, bacterial resistance 
against phage infection typically carries a cost to the host which results in reduced 
growth, productivity or other undesirable effects (34, 63, 64). This has led to 
numerous studies attempting to produce starter strains which are phage resistant 
but with minimal loss of productivity in yoghurt and cheese production (22, 23, 
65, 66), as well as biopesticide production (67). Given the current global antibiotic 
and food crisis studies into microbial community dynamics could now provide new 
data to help remedy or inform policy relating to the use of microbes in both natural 
and industrial applications helping to alleviate these issues. 
 
Phage defence mechanisms in bacteria 
Recent advances in ‘omics’ technologies have rapidly accelerated our ability to 
locate possible novel defence mechanisms resulting in a recent boom in the 
number of known defence mechanisms. Makarova et al (68) first analysed the 
distribution of defence genes on the bacterial genome and revealed they typically 
form clusters known as defence islands. Consequent studies have used similar 
methods and have identified and characterised numerous novel defence systems 
with great success (69, 70), reviewed in (70). Our mechanistic understanding of 
most of these putative systems is still in very early stages but many bacterial 
resistance mechanisms have been previously described and studied in more 
detail, such as Restriction-Modification (RM) systems, surface modification (sm), 
12 
 
Abortive Infection (Abi) (71) and prokaryotic argonaute proteins (pAgo) (72, 73), 
and these have been reviewed in (37, 74–76). 
Based on their mode of action phage defense mechanisms of bacteria can be 
broadly classified into three groups: resistance via cell dormancy and induction 
of programmed cell death, resistance based on variation of virus receptors, or 
resistance via immunity (69, 77, 78). Different types of defense are associated 
with different fitness costs which are thought to be key drivers of when different 
modes of phage defence evolve (79). Induced cell dormancy or death in response 
to phage infection prevents or delays the replication of phage within the infected 
host (77, 80), it has been hypothesised that this may “buy time” for the remaining 
host population to evolve immunity (37).Phage resistance via immunity relies on 
the ability of the immune mechanism to discriminate self from non-self DNA and 
to target only foreign DNA. Immune systems can be loosely categorised into two 
groups: Relatively non-specific innate immune systems or specific adaptive 
immune systems. Non-specific innate immune systems attack non-self DNA 
mostly indiscriminately. pAgos are a more newly discovered group of innate 
immune system and further research is needed to clarify the mechanism, costs 
and benefits of carrying this system (79, 81, 82). RM systems are a more well 
characterised example of innate defense mechanism which provide defence 
against phage as well as other mobile genetic elements (MGEs) (83–85), 
however carrying an RM system is thought to cause high rates of auto-immunity 
thereby making the system costly in the absence of maladaptive MGEs (86–88). 
CRISPR-Cas is a specific adaptive immune system which enables cells to 
“remember” previously encountered foreign DNA such as phage, plasmids or 
other MGEs. As in RM systems CRIPSR-Cas adaptive immunity functions by 
cleaving invading MGEs, however in contrast to innate immune systems 
cleavage is specific and guided by the “memory” of the adaptive immune system 
(89–92). CRISPR-Cas has found to carry an inducible fitness cost, i.e. the cost 
of defence increases with infection frequency (34). In contrast to the inducible 
cost of CRISPR-Cas immunity phage resistance which is acquired via alteration 
of receptors to which phage bind, preventing phage adsorption or injection, such 
as sm resistance (37, 93, 94) is associated with constitutive (fixed) fitness costs 
due to secondary effects of the physiological changes which can affect motility 
and biofilm formation (95), as well as growth rates (34, 64).  
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In the following studies we use an established laboratory bacteria-phage system 
to focus on when adaptive immunity with an inducible fitness cost (CRISPR-Cas) 
is favoured over sm resistance which is associated with a constitutive (fixed) cost.  
CRISPR-Cas and sm are the most common mechanisms for rapid evolution of 
de novo phage resistance, and therefore present an ideal system to study the 
selective pressures which drive the evolution of one type of defence mechanism 
over the other. We expect systems with different fitness costs will be favoured in 
different environments associated with different selective pressures, therefore by 
understanding what drives the evolution of one defence over another we can 
increase our ability to predict and manipulate microbial evolution. 
 
sm mediated resistance and CRISPR-Cas defence in microbial 
communities 
sm resistance and CRISPR mediated defence have been shown to be important 
in microbial ecological interactions (76, 79, 96). This is due to the rapid rate of 
evolution, compared to RM and Abi systems, meaning sm and CRISPR mediated 
immunity respond much more rapidly to changes in environment, with CRISPR 
loci evolution patterns consistent with an important role in antagonistic co-
evolution with sympatric viruses (36). Horizontal gene transfer is thought to be 
one of the major ways CRISPR-Cas defence is acquired (97–101) while sm 
resistance is acquired via mutation, downregulation, loss or masking of the 
receptor to which the phage binds (94). sm mutations have been associated with 
a fitness cost, or increased susceptibility to another virus (64). While carrying a 
CRISPR loci does not appear to have a significant fitness cost compared with a 
sensitive strain in the absence of phage (34), it does not provide resistance 
against the same range of phage genotypes as sm resistance. It also may be 
costly to carry a CRISPR-Cas system when beneficial plasmids are present, for 
example plasmids conferring antibiotic resistance in an environment where 
antibiotics are present may be targeted by CRISPR-Cas as invading DNA (102). 
The evolution of bacterial immune defence drives diversification in phage 
populations resulting in phage which are able to overcome bacterial defences 
(37, 103). Phage have been found to evolve to overcome sm resistance using 
carbohydrate degrading enzymes (104) and overcome other types of receptor 
14 
 
modification by mutation within the phage genome which allows the phage to 
adsorb to the altered receptor (105). Comparatively, phage can evolve to 
overcome CRISPR-based resistance relatively easily by a single point mutation 
(106), in a specific region of the targeted sequence. These mutations arise 
frequently and are typically not costly to the phage, however the fitness cost 
associated with maintaining these mutations will likely depend on a range of 
variables, including the number of point mutations previously acquired and host 
diversity (103). When phage evade targeting by an existing spacer, bacteria are 
only able to re-gain resistance by acquiring a new spacer matching the new 
phage genotype (107).  
Evolution of sm mediated phage defence has been associated with various traits 
of interest such as virulence factors, the ability to form biofilms (50–52), and 
transfer MGEs (49). The secondary effects of carrying a CRISPR-Cas system are 
less clear. Understanding when sm defence evolves over CRISPR-Cas 
resistance could have direct applications in medical or industrial settings. By 
comparing rates of evolution of a phage defence mechanism associated with a 
fixed fitness cost and broad range of phage resistance, such as sm, with a 
specific resistance mechanism with a varying fitness cost such as CRISPR-Cas 
we can gain insight into when one type of defence or resistance is likely to evolve 
over the other. This data will help us to predict and manipulate the evolution of 
microbial communities where these systems are present as well as contributing 

















Box 1 continued 
CRISPR-Cas Mechanism: (1) Adaptation takes place when a bacterial cell 
encounters a novel phage; Cas (CRISPR-associated) proteins detect and target 
the invading DNA via recognition of a specific sequence known as a PAM 
(Protospacer Adjacent Motif). (2) A portion of the phage genome (known as a 
protospacer) is then cleaved and incorporated into the CRISPR loci (107, 108) 
where it is known as a “spacer” in the CRISPR array  (109). Expression happens 
when the CRISPR array is transcribed as a precursor transcript (pre-crRNA), 
which is processed and matured to produce CRISPR RNAs (crRNAs). (3) Finally, 
during interference processed CRISPR transcripts form a crRNA-effector 
complex which guide Cas proteins to detect and destroy re-infecting phage that 
carry the cognate target sequence (89–92, 110, 111). 
 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats; 
CRISPR-associated) adaptive immune systems are found in approximately 30% 
of bacteria (78) and around 90% of archaea. In most CRISPR-Cas systems there 
are 3 main stages to acquisition of immunity; adaptation, expression and 
interference (see box 1). Phage can in turn evolve to overcome CRISPR-based 
resistance by point mutation in the PAM sequence on their genome (106), 
although the emergence and spread of such phage “escape” mutants is 
constrained by both the diversity of CRISPR resistance alleles in the bacterial 
population and the fitness costs associated with the phage mutations (35, 112–
114). More detailed reviews of the intricacies of CRISPR-Cas defence can be 
found in the following (108, 115–120). 
We are already aware of a wide range of CRISPR-Cas variants divided into 2 
classes, 6 types and 33 subtypes. Classification of CRISPR-Cas systems is 
based on a range of factors including signature genes, gene repertoire 
comparison and genomic loci organizations (2). The 2 main classes are 
distinguished by the architecture of the proteins which locate and cleave invading 
target sequences, known as effector complexes. In class 1 systems the effector 
complex produced during the expression stage is made up of multiple Cas 
proteins forming a multisubunit to which the matured guide crRNAs bind. In Class 
2 systems the guide crRNA binds with a single multidomain protein. Research 
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into Class 2 CRISPR-Cas systems has advanced rapidly in recent years driven 
by the desire for new genome editing tools  (121–130), however class 1 systems 
are by far more prevalent in nature (100). While research into Class 2 systems 
has yielded vital and revolutionary laboratory techniques research into Class 1 
systems is far more relevant to natural scenarios. It has also been suggested that 
some Class 1 derived variants of CRISPR-Cas may perform functions other than 
adaptive immunity (119, 131, 132) highlighting our lack of understanding of 
CRISPR-Cas function in nature and the need for further investigation into Class 
1 CRISPR-Cas systems. 
 
Understanding CRISPR-Cas in ecologically relevant contexts 
Most laboratory experiments use clonal phage and bacterial cultures when 
investigating the evolution of CRISPR-Cas, which is not representative of typical 
natural scenarios. To date most studies have focused on either the evolution of 
CRISPR-Cas at the individual level or the evolution of CRISPR-Cas in isolation 
of other traits. It has been shown that diversity of a Class 1 CRISPR-Cas system 
at the population level was an important driver in the evolutionary outcome of 
phage infection on both the host and phage populations (35), and it has recently 
been shown that the evolution of CRISPR-Cas is influenced by the local microbial 
community (133). These insights are relatively new and highlight how the 
reductionist approach taken by many previous studies hampers our ability to 
understand the ecological relevance of CRISPR-Cas in nature. 
 
Genetic diversity is likely an important determinate of CRISPR-Cas 
evolutionary dynamics 
Despite advances in our mechanistic understanding of the different defence 
strategies of bacteria, the ecological conditions that favour one type of defence 
over another remain unclear (36, 79). High levels of within-population CRISPR 
spacer diversity have been found in nature (134–136) and it has been shown in 
laboratory experiments that bacterial population resistance increases with the 
number of unique spacers present in the population (35). High population level 
CRISPR-allele diversity results in increasingly rapid phage extinction (35), and 
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bacterial species diversity increases selection for CRISPR-Cas evolution (133). 
Intuitively, phage genetic diversity is likely to be an important determinant of when 
CRISPR-based resistance or sm based immunity evolves since the latter 
generally provides more broad-range resistance compared to the sequence-
specific resistance of CRISPR-Cas. Because CRISPR-Cas needs a spacer 
targeting an infecting phage in order to recognise and destroy the phage each 
infection by a new genotype requires the acquisition of a new spacer to provide 
resistance.  
Theoretical models support the idea that diversity is an important driver in the 
evolution of CRISPR-Cas resistance with increasing phage diversity increasing 
the cost of CRISPR-Cas resistance through cost of new spacer acquisition and 
system activation costs (137, 138). This idea is supported by correlational 
studies, which suggest that CRISPR-Cas immune systems are over-represented 
in thermophiles, which tend to have a lower mutation rates (137–140) and have 
lower host and parasite densities (137). Apart from accelerating the evolution of 
“escape” phages, high mutation rates will also increase the rate at which surface 
based resistance evolves (141). Empirical evidence is needed to determine the 
importance of phage diversity in the evolution of CRISPR-Cas. 
 
Cell-Cell communication may influence CRISPR-Cas evolution 
There has been suggestion that CRISPR-Cas evolution could be manipulated via 
alternate methods, for example it has been shown that inhibiting Quorum Sensing 
(QS), a cell-cell communication system used by bacteria reduces the production 
of the Cas protein involved in DNA cleavage (142). Since CRISPR-Cas is 
selected for at low cell densities (under low risk of infection), it is unsurprising that 
it would be regulated by a mechanism which monitors cell density, however 
research has shown that QS is more important at high cell densities so the 
strength of interaction between QS and CRISPR-Cas remains unclear as we 
expect each system to be important in contrasting environments. Evolution 
experiments are required to directly test the outcome of QS inhibition on CRISPR-
Cas resistance evolution to validate if this may be a viable approach to 




Can we manipulate CRISPR-Cas evolution to our advantage? 
The CRISPR-Cas machinery has proved to be a powerful tool in genome editing 
as it is a specific, accurate and programmable mechanism and numerous 
methods of manipulating CRISPR-Cas to our advantage have been already been 
proposed (143). The presence of CRISPR-Cas in natural microbial communities 
could present an opportunity to manipulate the CRISPR-Cas system to target 
undesirable MGEs such as plasmids containing antimicrobial resistance genes 
(102). Some studies have already suggested that by inserting or manipulating a 
CRISPR-Cas system in bacteria used in industry involving high density cultures 
of bacteria which are susceptible to phage infection (for example in yoghurt and 
cheese production) we could reduce the volume of product which is lost to phage 
infection by providing resistance with minimal loss of productivity (144). This 
method may also be applicable to the production of B. thuringiensis spores which 
are fermented in high densities and so are also susceptible to phage infection. 
However, the presence of CRISPR-Cas resistance in a bacterial population 
would potentially be undesirable in alternate scenarios, for example in phage 
therapy where the presence and rapid adaptation of CRISPR-Cas could result in 
eradication or reduced efficacy of the applied phage cocktail and the evolution of 
phage resistant virulent cells.  
 
Aims and Objectives 
Here I explore the importance of CRISPR-Cas ecology investigating both within 
genome and within population outcomes of bacteria-phage interactions. I have 
specifically focused on two possibly influencing factors which have recently been 
indicated to be involved in CRISPR-Cas evolution: Firstly I investigate the role of 
genetic diversity within a phage population, which has been predicted to be an 
important influence of CRISPR-Cas evolution (137) and population level diversity 
in the CRISPR-Cas locus of a host population has also been shown to be an 
important driver of CRISPR-Cas evolution (35). Secondly, I investigate the 
importance of QS in the evolutionary outcome of phage infection on CRISPR-Cas 
since QS has been shown to affect the expression of a vital CRISPR-Cas 
component (53) but the importance of this in the evolution of CRISPR-Cas in 
response to phage infection is not known. 
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In this thesis I investigate the evolutionary and ecological importance of CRISPR-
Cas evolution, specifically focusing on when the evolution of sm (fixed cost) 
resistance is favoured over the evolution of CRISPR-Cas (inducible cost) 
resistance. The data presented here provide insights into the ecological 
conditions which favour one type of defence over the other and can inform any 
studies investigating systems where CRISPR-Cas is present, including in clinical, 
natural and industrial settings. 
Chapter 1: Phage adaptation in the context of diverse CRISPR resistance alleles 
High within-population CRISPR-Cas allele diversity is often observed in natural 
systems but it is unclear why this is important. Here I use bacterial populations 
harbouring varying levels of CRISPR allele diversity to investigate: 
1. The role of within-population CRISPR allele diversity in phage defence. 
2. How CRISPR allele diversity affects the ability of phage to overcome 
targeting by CRISPR-Cas and how this affects local adaptation to hosts by 
phage. 
Chapter 2: The Effect of Phage Genetic Diversity on Bacterial Resistance 
Evolution 
Using an experimentally evolved phage population with increased within-
population genetic diversity I test: 
1. How within-population phage diversity affects when the evolution of 
CRISPR-Cas is favoured over sm in infected populations. 
2. The effect of within-population phage diversity on the rate of CRISPR 
spacer acquisition 
3. Differences in rates of phage extinction/persistence when phage 
populations differ in within-population diversity. 
Chapter 3: The interaction between Quorum Sensing and CRISPR-Cas evolution 
Based on findings that QS plays a role in activation of CRISPR-Cas I manipulate 
QS to test: 
1. How inhibiting QS affects the evolutionary dynamics of CRISPR-Cas, 




2. If QS manipulation affects the fitness of bacteria in the presence of phage 
3. For secondary phenotypic effects induced by QS inhibition which may 
influence bacterial fitness 
 
Study system 
Pseudomonas aeruginosa is a well-studied model organism, it is environmentally 
ubiquitous (145), known to cause infections in a range of hosts (146–148). Single 
strains of P. aeruginosa are capable of infecting multiple host species, it is 
prevalent in nosocomial infections and is capable of causing chronic and acute 
infections in humans (149, 150). It is the main pathogen causing chronic lung 
infections and leading cause of mortality in Cystic Fibrosis patients (151). 
Research into the development of new antimicrobials effective against P. 
aeruginosa is listed as of critical importance by the World Health Organisation 
(152) with multiple strains now found to be resistant to our last-line of defence 
antibiotics such as β-lactams and carbapenem (149). In our search for 
alternatives to antibiotic treatments research into phage therapy has seen a 
reawakening in recent years with P. aeruginosa frequently being the target 
species (153–155) with some reports of successful eradication of virulent strains 
via phage therapy (56).  
P. aeruginosa strain PA14 and its phage DMS3vir (156) are an established 
laboratory model system for studying the evolution of CRISPR-Cas. P. 
aeruginosa PA14, originally isolated from a human infection (157) carries a type 
I-F CRISPR-Cas system, has a broad host range and is of primary concern in 
nosocomial infections (148). The phage DMS3 is a mu like phage, originally 
isolated from a pathogenic strain of PA14 and infects bacterial cell via the Type 
IV Pilus  (158). Here we use an engineered obligately lytic version of DMS3, 
DMS3vir (156). Under laboratory conditions PA14 evolves resistance to DMS3vir 
through either CRISPR-Cas defence or sm resistance. Research using this 
organism then has direct applications to the management of problematic P. 
aeruginosa strains in clinical or natural environments but will also provide more 
general knowledge about the evolutionary dynamics which dictate when different 



















The prokaryotic adaptive immune system CRISPR-Cas is known to play an 
important role in bacteria-phage dynamics. CRISPR-Cas provides sequence 
specific immunity by inserting sections of foreign DNA into the host genome as 
“spacers”, allowing hosts to detect and destroy invading DNA of viruses and other 
parasitic mobile genetic elements. CRISPR-Cas is a highly specific defense 
mechanism, and in theory this could lead to ongoing co-evolution and local 
adaptation. Host populations possessing CRISPR-Cas have been shown to 
develop high within- population spacer diversity, and increasing levels of CRISPR 
allele diversity in a host population can prevent phage from becoming locally 
adapted.  However, increased levels of phage diversity can increase phage 
adaptation, and  CRISPR-Cas diversity can drive the evolution of genetic diversity 
in phage populations, and vice-versa.  The relationships between CRISPR-cas 
diversity and local adaptation may therefore be complex.  Here I reanalyse data 
derived from previous work to investigate in more detail the relationship between 
host CRISPR allele diversity and the evolutionary effects that has on phage 
populations. Specifically, I quantify and look for relationships between CRISPR 
allele diversity, phage local adaptation, phage diversity and rates  phage 
evolution (genetic distance from ancestor). I show that increasing CRISPR allele 
diversity in a host population reduces the evolutionary potential of phage to 
become locally adapted. This is a because increasing CRISPR allele diversity 
reduces the amount of genetic diversity which evolves in the phage population, 
and therefore the likelihood of local adaptation occurring. These new analyses 
help us understand in more detail the intricate balances in host-parasite evolution 
and indicate which variables are important for ongoing co-evolution. 
 
Introduction 
CRISPR-Cas is a prokaryotic adaptive defence mechanism which allows hosts 
to target previously encountered phages and other parasitic mobile genetic 
elements (109). The mechanism of CRISPR-Cas has been described in detail 
previously (108, 115, 118, 120). In brief, there are three stages to CRISPR-Cas 
defence: 1) During adaptation a section of DNA is cleaved from the phage 
genome (where it is known as a protospacer) and integrated into the CRISPR 
24 
 
array as a spacer (107). 2) Expression of the CRISPR array and subsequent 
cleaving of the array produces mature guide CRISPR-RNAs (crRNAs) 
complementary to single spacers acquired from previously encountered foreign 
DNA elements (159). 3) Interference occurs when CRISPR-associated (Cas) 
proteins bind with the mature crRNAs which serve as guides for the Cas proteins 
to cleave foreign DNA complementary to the spacer, destroying the invasive DNA 
(160). Mature crRNAs detect foreign genetic elements via highly specific base-
pairing with a short string of nucleotides within the protospacer  known as the 
seed region, as well as a highly-conserved sequence directly adjacent to the 
protospacer on the phage genome termed the protospacer-adjacent motif (PAM; 
see (161)). It has been suggested that the absence of PAMs in the host CRISPR 
loci helps to prevent autoimmunity (162), however the high specificity of binding 
during interference by CRISPR-Cas means that phage are able to evade 
targeting via single point mutations in the PAM or protospacer regions (34, 106). 
High infection specificity can lead to ongoing coevolution (137, 163, 164). Indeed, 
phage have been reported to persist in wild-type populations of Streptococcus 
thermophilus for at least 30 days (136); although this length of co-evolution under 
laboratory conditions is unusual (34, 35, 165) and may be attributed to the lower 
rate of spacer acquisition and high number of duplicate spacers that S. 
thermophilus is known to acquire (135, 136) compared to other bacteria.  
 
Most of our knowledge of the evolution of CRISPR-Cas comes from laboratory 
studies using clonal bacteria and phage stocks. In bacteria-phage interactions in 
nature we expect much higher levels of diversity in both bacteria and phage 
populations.  While phage are able to escape CRISPR-Cas targeting relatively 
easily when there is only one spacer targeting them, as spacer diversity within a 
host population increases so does the number of mutations phage require to 
escape targeting making them less able to adapt to host populations (35).  Under 
the assumptions that the infection process is specific, that a parasite genotype 
can infect a restricted number of host genotypes and that a failed infection results 
in parasite death, it is predicted that host genetic diversity will prevent parasites 
from spreading through the population (112, 137, 164, 166–171). Since this 
results in fewer successful infections the viral population size (166, 167), and 
therefore genetic diversity, is minimised, reducing the likelihood of the emergence 
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of phage which can escape CRISPR-Cas targeting. As spacer diversity within a 
host population increases so does the number of mutations required for phage to 
escape targeting (35), concurrently diverse phage are more able to infect host 
populations and are more likely to elicit the acquisition of multiple spacers in 
CRISPR-resistant hosts (43). This indicates a complex role of genetic diversity in 
bacteria-phage interactions which is currently poorly understood.  
 
In a specific interaction such as that between CRISPR-Cas resistant hosts and 
infecting phage the ability of phage to become locally adapted is predicted to be 
affected by genetic diversity (172–174). Local adaptation can be said to have 
occurred when an organism is more adapted to one environment than another 
(for example, when a phage is more infective against sympatric than allopatric 
hosts) (174). Understanding how and when local adaptation occurs will help us 
to understand what traits are favoured in different environments as well as how 
natural selection functions relative to gene flow or other evolutionary drivers 
(174). Assuming a parasite genotype needs to match the host genotype for 
infection to occur, increasing the number (diversity) of host genotypes will reduce 
the potential for local adaptation (175) because it will reduce both between host 
population differentiation and mean infectivity across all populations. The 
reciprocal argument holds if resistance is determined by matching: more parasite 
genotypes (more diverse parasites) decrease differentiation between parasite 
populations and mean resistance.   Given that host inter and intra population 
diversity affects the diversity of infecting parasites and vice versa, this can lead 
to complex relationships between genetic diversity and patterns of local 
adaptation.   
 
Here I present data which is a collation and re-analysis of results from two 
collaborative projects I worked on. The first project investigated the effect of 
CRISPR allele diversity within a host population on the ability of phage to infect 
the population (35) and the second looked at the resultant impact of host CRISPR 
allele diversity on parasite local adaptation (165). During the first project we 
created host populations harbouring increasing levels of CRISPR allele diversity 
and then monitored phage infectivity over time to test the effect of CRISPR allele 
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diversity on phage persistence and evolution. We found phage are less able to 
infect a host population as host CRISPR allele diversity increases. The second 
project looked at phage local adaptation as a function of differing levels of 
CRISPR allele diversity using evolved phage and CRISPR host populations from 
the first project. We calculated the level of phage local adaptation to host 
populations by measuring phage infectivity against hosts which were or were not 
present in their host population. I extend this work in two key ways. Firstly, I 
determine accurate levels of host diversity; due to duplication of spacers within 
host populations used in these studies host diversity was overestimated. I correct 
for this and use the new data to investigate the role of host diversity in phage 
evolution in more detail. Secondly, I determine how genetic changes in the 
evolved phages resulting from the different host diversity treatments correlate 
with phage local adaptation. Specifically, I determine how phage genetic diversity 
and the extent to which phage have evolved (genetic distance from their 
ancestor) correlate with local adaptation. All things being equal, high phage 
diversity should lower local adaptation rates, while genetic distance from ancestor 
should increase, because populations will be more differentiated. However, the 
possible correlation between these two phage measures as well as host diversity, 
makes the outcomes unclear. My new analyses demonstrate that increasing host 
CRISPR allele diversity greatly impacts the amount of phage adaptation and that 
increasing CRISPR allele diversity limits the evolution of genetic diversity and the 
extent to which phage can become locally adapted.  
 
Methods 
The following experiments were performed by van Houte et al (35), I assisted in 
running and processing data from the competition experiments and extracting the 
evolved phage which were used in follow up work: Myself and Dan Morley tested 
each phage isolate for infectivity against sympatric and allopatric hosts (see (165) 
for full analyses). Consequent to these papers being published it was discovered 
that some of the CRISPR-resistance hosts used in these experiments harboured 
either multiple or duplicate spacers. In this chapter I use this data to investigate 
how variables such as phage genetic diversity and genetic distance from ancestor 
correlate with local adaptation and host population CRISPR allele diversity. 
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Below are brief methodologies of how data was generated, please see the 
original papers (35, 165) for full details and alternate analyses. 
 
Previously published experimental work 
Bacterial strains and viruses 
P. aeruginosa UCBPP-PA14 (WT), P. aeruginosa UCBPP-PA14 csy3::LacZ 
(referred to as CRISPR KO, which carries a disruption of an essential cas gene 
and can therefore not evolve CRISPR immunity), the CRISPR KO-derived 
surface mutant and virus DMS3vir have all been described in (34) and references 
therein. Phage DMS3vir+acrF1, which carries the anti-CRISPR gene acrF1 
(formerly known as DMS3vir 30-35), was made by inserting acrF1 into the 
DMS3vir genome using methods described in (176). Streptococcus thermophilus 
strain DGCC7710 and its virus 2972 have been described in (109). 
 
Generation of populations with different levels of CRISPR diversity 
48 individual clones that had acquired CRISPR immunity against virus DMS3vir 
were isolated from the 6 replicates of the coevolution experiment described in 
Fig. 1 in (35). It has previously shown that individual clones tend to have unique 
spacers (34). Using these 48 clones, populations with five different levels of 
CRISPR spacer (allele) diversity were generated. These populations consisted 
of: 1) 1 clone (a monoculture; a clonal population carrying a single spacer); equal 
mixtures of 2) 6 clones; 3) 12 clones; 4) 24 clones and 5) 48 clones. In total 48 
different monocultures (48 x monocultures), 8 x 6-clone populations, 4 x 12-clone 
populations, 2 x 24-clone populations and 1 x 48-clone population were 
generated. 
 
To ensure equal representation of each of the 48 clones across the different 
treatments, the number of replicate experiments for a given diversity treatment 
was adjusted accordingly, with a total number of replicates of at least six for 
sufficient statistical power. Hence, competition experiments with the one-clone 
(monoculture) populations were performed in 48 independent replicates, each 
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corresponding to a unique monoculture of a CRISPR clone (clones 1–48; each 
clone is equally represented). Competition experiments with the 6-clone 
populations were performed in eight independent replicates, each corresponding 
to a unique polyculture population (population 1: equal mixture of clones 1–6; 
population 2: clones 7– 12; population 3: clones 13–18; population 4: clones 19–
24; population 5: clones 25–30; population 6: clones 31–36; population 7: clones 
37–42; population 8: clones 43–48). Competition experiments with the 12-clone 
populations were also performed in eight replicates, corresponding to four unique 
polyculture populations (replicate 1 and 2: clones 1–12; replicate 3 and 4: clones 
13–24; replicate 5 and 6: clones 25–36; replicate 7 and 8: clones 37–48). 
Competition experiments with the 24-clone populations were performed in six 
replicates, corresponding to two unique polyculture populations (replicate 1–3: 
clones 1–24; replicate 4–6: clones 25–48). Competition experiments with the 48-
clone populations were performed in six replicates, each corresponding to the 
same polyculture population (replicate 1–6: clones 1–48). 
 
Competition experiments in P aeruginosa 
Competition experiments were done in glass microcosms in a total volume of 6 
ml M9 supplemented with 0.2% glucose. Competition experiments were initiated 
by inoculating 1:100 from a 1:1 mixture (in M9 salts) of overnight cultures of the 
appropriate P aeruginosa CRISPR population and the surface mutant. At the start 
of each experiment 109 pfu of DMS3vir was added, unless indicated otherwise. 
Cultures were transferred daily 1:100 into fresh broth. At 0 and 72 hours post-
infection (hpi) samples were taken and cells were serially diluted in M9 salts and 
plated on LB agar supplemented with 50 μg.ml-1 X-gal (to allow discrimination 
between WT-derived CRISPR clones (white) and CRISPR KO or surface mutant 
(blue)).  
 
Effect of spacer diversity in Streptococcus thermophilus  
Streptococcus thermophilus DGCC7710 was grown in M17 medium 
supplemented with 0.5% α-lactose (LM17) at 42°C. Virus 2972 was used 
throughout the experiments. Virus infections were carried out using 106 pfus of 
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phage 2972 and 10mM CaCl2 to facilitate the infection process. To obtain virus-
resistant S. thermophilus clones, a sample of virus lysate at 24 hpi was plated on 
LM17 agar plates. Individual colonies were picked and PCR-screened for the 
acquisition of novel spacers in each of the 4 CRISPR loci, as described in (109). 
A total of 44 individual clones with a novel spacer in CRISPR1 (see (164) and 
references therein) were selected to generate 44 monocultures and a single 
polyculture comprised of a mix of 44 clones. These cultures were infected with 
107 pfu of virus, and samples were taken after the indicated periods of time to 
isolate virus. We determined virus titres by spotting viral dilutions on lawns of 
ancestral bacteria, and the emergence of escape virus by spotting virus on lawns 
corresponding to each of the 44 CRISPR resistant clones. 
 
Determination of escape virus emergence 
To determine the emergence of escape virus during the competition experiments, 
every isolated virus sample was spotted onto 48 (P aeruginosa) or 44 (S 
thermophilus) different bacterial lawns, corresponding to each of the different 
CRISPR clones present in the competition experiments. This procedure was 
done for each of the seven time points (see above), to enable us to track the 
emergence of escape virus against every individual clone over the time course of 
the experiment.  
 
Deep sequencing 
Isolated phage samples from t=1 dpi of the competition experiment shown in Fig. 
1 were used to perform deep sequencing of spacer target sites on the phage 
genomes. To obtain sufficient material, phage were amplified by plaque assay on 
the CRISPR KO strain. Viruses from all replicates within a single diversity 
treatment were pooled. As a control, ancestral virus and escape virus from 
competition between sm and monocultures of CRISPR clones 1-3 were 
processed in parallel. Virus genomic DNA extraction was performed from 5 ml 
sample at approximately 1010 pfu/ml using the Norgen phage DNA isolation kit, 
following the manufacturer’s instructions. Barcoded Illumina Truseq Nano 
libraries were constructed from each DNA sample with an approximately 350bp 
insert size and 2x 250bp reads generated on an Illumina MiSeq platform. Reads 
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were trimmed using Cutadapt v1.2.1 and Sickle v1.200 and then overlapping 
reads merged using Flash v1.2.8 to create high quality sequence at 
approximately 8000x coverage of DMS3vir per sample. These reads were 
mapped to PA14 and DMS3vir genomes using bwa mem v0.7.12 and allele 
frequencies of Single Nucleotide Polymorphisms (SNPs) within viral target 
regions quantified using samtools mpileup v0.1.18. Further statistical analyses 
were performed in R v3.2.2. Sequence data are available from the European 
Nucleotide Archive under accession PRJEB12001 and analysis scripts are 
available from https://github.com/scottishwormboy/vanHoute. 
 
Measuring local adaptation of phage to host populations competed with a 
phage-immune host 
To investigate the extent of phage local adaptation to host populations which had 
occurred during the previously described experiment I conducted follow up 
experiments with Dan Morley (previously published (165). We took evolved 
phage from the experiment described above from 1,2 and 3 dpi and tested their 
ability to infect hosts which were in the host population which the phage had 
evolved with (allopatric hosts) or hosts which the phage had not been evolved 
with (sympatric hosts). To do this we performed spot assays on monoculture 
bacterial lawns of each of the host bacteria used in the mixed host populations 
so each phage population was tested for infectivity against both allopatric and 
sympatric hosts. Here phage “performance” was measured as the ability to infect 
a CRISPR clone. Phage local adaptation was analysed by subtracting the 
performance of allopatric phages from the performance of the sympatric phage 
for each host (‘foreign vs. local’) and by subtracting the performance of a phage 
population on allopatric hosts from the performance of that phage population on 







New Analyses of Data  
Quantifying SNP frequencies 
Following evolution on host populations harbouring increasing levels of CRISPR 
allele diversity van Houte et al (35) performed deep sequencing on the regions of 
the phage genome targeted by each of the CRSIPR spacers (Fig. 2). In order to 
prepare this data (raw data available from 
https://github.com/scottishwormboy/vanHoute) I corrected for any selection bias 
that may have been introduced by duplicate spacers within a group as well as 
accounting for dilution effects which occurred during the sequencing process due 
to treatments being pooled. To do this the following formula was applied to each 
sequenced target region for each phage group: 
SNP frequency x (number of groups in treatment/number of duplicate spacers at 
target site present in group) 
This provided me with a corrected SNP frequency for each site on the phage 
genome targeted by one of the CRISPR resistant hosts in the set of 48 BIMs 
which made up the populations the phage were evolved on. I was then able to 
use this data to quantify phage diversity, and the difference between the evolved 
and ancestral phage at each target site (see below).  
 
Quantifying Diversity 
Using the phage SNP data described above and shown in Fig. 2 I applied a gini-
simpson’s diversity calculation to each sequenced target site. I used the formula, 
where P is the SNP frequency within a phage sample at a given target site: 
(1-(P^2))+((1-P)^2)) 
 
Calculating genetic distance from ancestor 
Using the phage SNP data described above and shown in Fig. 2 I calculated the 




SNP freq. of evolved phage at target site/SNP freq. of ancestral at same target 
site 
 
Quantifying phage local adaptation 
I initially applied both the ‘foreign vs. local’ and ‘home vs. away’ measures of local 
adaptation suggested by Kawecki and Ebert (2004) (174), however, as in the 
findings presented in Morley & Broniewski (2016) (165) the difference in the 
results of these two measures was negligible. I therefore used the ‘foreign vs. 
local’ formula to calculate levels of local adaptation for further analysis and 
collation with other data sets. The ‘foreign vs. local’ value is calculated by 
subtracting the performance of allopatric (foreign) phages from the performance 
of the sympatric (local) phage for each of the 48 clones from work with van Houte 
et al (35) where phage performance was defined as ability to infect a given host. 
 
Results 
Infectivity evolution and phage persistence 
I assisted van Houte et al (35) in investigating the idea that increasing CRISPR-
allele diversity within a host population would make phage less able to infect that 
population. To generate the data I have shown here in Figure 1 bacterial 
populations were generated in which the level of spacer diversity was 
manipulated. Using 48 individual clones with CRISPR-based immunity against 
virus DMS3vir bacterial populations with five distinct diversity levels were 
generated: monocultures or polycultures consisting of equal mixtures of either 6, 
12, 24 or 48 clones. To allow for direct comparisons, each of the 48 clones was 
equally represented at each diversity level by adjusting the number of replicate 
experiments accordingly. Each population was competed against a previously 
described strain of P aeruginosa PA14 which has a mutation in the receptor 
where the phage bind with the host, preventing phage infection (34). This is 
known as surface mutant (sm) based resistance and provides defence against a 
range of phage genotypes as opposed to the very specific mechanism of CRISPR 
based immunity. The competitions were performed in the presence or absence 
of virus DMS3vir and the evolution of viral ability to overcome CRISPR resistance 
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alleles was monitored over time. To this end, virus isolated from each time point 
(0, 16, 24, 40, 48, 64 and 72 hours post-infection) was spotted onto lawns of each 
of the 48 CRISPR clones. To test that our results were not limited to the P 
aeruginosa PA14 Type I-F CRISPR-Cas system, we performed a similar 
experiment with Streptococcus thermophilus DGCC7710 clones that evolved 
resistance against virus 2972 using a Type II-A CRISPR-Cas system. As shown 
in Fig. 1B, we found a similar effect of CRISPR based resistance allele diversity 
on escape virus emergence.  
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 Figure 1A         Figure 1B 




As expected, we could not detect escape virus in the ancestral virus (Fig. 1A and 
1B; left column, indicated in green). However, in P. aeruginosa 43 of the 48 
CRISPR monocultures, virus evolved within 2 days to overcome CRISPR based 
immunity (Fig. 1A; indicated in red). The emergence of escape virus decreased 
as diversity increased to 6, 12, 24 and 48 CRISPR alleles (Fig. 1A); in the latter 
two, no escape virus could be detected. These phenotypic data were supported 
by results of deep sequencing of virus genotypes isolated from 1 dpi: there was 
a significant inverse relationship between host diversity and the accumulation of 
viral mutations in the target sequences (Fig. 2). This is because virus needs to 
overcome multiple spacers in the diverse host population if it is to increase in 
frequency. These results are replicated in S. thermophilus where we see escape 
phage in 35 of the 44 monoculture treatments but no escape phage against the 
diverse treatments (Fig. 1B). 
 
For 5 of the P. aeruginosa clones no escape virus could be detected, and virus 
went extinct in 4 of these instances (Fig. 1A, asterisks). Following sequencing of 
these clones it was discovered that three of these 5 clones carried multiple 
spacers targeting the virus, which limits the emergence of escape virus (164), 
furthermore, it was discovered that some spacers were duplicated within the set 
of 48 clones. Although this does not affect the results of this publication it provides 
Figure 1. Evolution of virus infectivity is constrained by spacer diversity  
Figure 1A Emergence of virus that overcomes P aeruginosa CRISPR mediated 
immunity (escape virus) over time. Table columns correspond to time points where 
virus was isolated (0, 16, 24, 40, 48, 64 and 72 hours post-infection; indicated below 
the table in days post-infection). Green: no escape virus. Red: escape virus. Bold 
numbers indicate individual biological replicates, as detailed in the legend of Figure 
2. In columns B-E replicates are separated by bold lines in the table. Numbers 
between parentheses refer to the clones in the CRISPR population. Asterisks 
indicate virus extinction. Figure 1B Emergence of virus mutants that overcome S 
thermophilus CRISPR-mediated immunity after 0, 16, 24, 40 and 48 hours post-
infection. Green indicates no escape virus. Red indicates emergence of escape 
virus. Escape virus emerged in none of the polyculture experiments. 
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an opportunity to look at the role of diversity in the host population in more depth 
with new analyses. Data from this experiment was correlated with data from figure 
2 and 3 in figures 6, 7 and 8 to further investigate the effect of CRISPR spacer 
diversity on infecting phage populations. 
 
Phage evolution in response to varying host CRISPR allele diversity 
van Houte et al (2016) (35) performed deep sequencing of the evolved phage 
populations to look for SNPs in the PAM or seed region of the phage genome 
following evolution on host populations carrying 1, 6, 12, 24, or 48 unique 
CRISPR alleles. After correcting for the increased selection on sites targeted by 
duplicate spacers I found that SNP frequency decreased as host population 







The data here show that when host CRISPR allele diversity is low parasites are 
able to rapidly overcome CRISPR based immunity in a host population (Fig. 1A, 
column a) but that when a host population harbours increasing levels of CRISPR 
diversity the parasites are less able to infect (Fig. 1A, columns b-d). The inverse 
relationship between host diversity and viral mutations in regions targeted by 
CRISPR and the rapid evolution within the CRISPR-phage interaction suggests 
that under the right conditions antagonistic evolution may occur. Using the 
corrected SNP frequency data I calculate levels of genetic diversity in evolved 
phage populations and how genetically different they are from the ancestral 
phage. I then correlate these variables with levels of host population CRISPR 
allele diversity (Fig. 1) and local adaptation (Fig. 3). 
 
Local adaptation 
Using the original data from the experiments presented in (165) I reanalysed the 
data to confirm I found the same trend. My results replicate that of Morley et al; I 
found that the  ‘home vs away’ and ‘foreign vs ‘local’ metrics suggested by 
Kawecki et al (174) showed a significant negative effect of increasing CRISPR 
allele diversity within a host population and the amount of phage local adaptation. 
I found that both metrics gave the same values and there was <0.0001 difference 
in the 95% Confidence Intervals upon analyses so I have used the ‘foreign vs 
local’ to quantify local adaptation in the following figures and analyses. 
Figure 2. Spacer diversity reduces the frequency of SNPs in infecting phage 
Deep sequencing analysis of the frequency of mutations in the seed region and 
PAM of the target sequence of virus isolated at t=1 from the experiment shown in 
Fig. 1 after correction for dilution effects and selection bias due to duplicate spacers 
within treatment groups. Bars show average frequency of point mutation across all 
target sites in the ancestral virus genome and in the genomes of virus from pooled 
samples of all biological replicates from a single diversity treatment, error bars show 







As in (165) I found that phage evolved in monoculture were more locally adapted 
than when evolved on multiple hosts (Wilcoxon test: p < 0.0001, W = 616). Using 
this data combined with the phage diversity and ancestral distance data derived 
from the SNP frequency data shown in Fig. 2 I investigated the relationship 




Figure 3. Phage local adaptation decreases as host spacer diversity increases 
Phage local adaptation which occurred during the experiment shown in Fig. 1. Local 
adaptation was quantified using the ‘foreign vs local’ metric, bars show average 
values of local adaptation for each diversity treatment, error bars show 95% 




Quantifying evolved genetic change in phage after evolution on hosts with 
varying CRISPR allele diversity levels 
Figure 4 
One way of quantifying the effect of varying CRISPR allele diversity on a phage 
population is to compare the evolved phage with the ancestral phage. To this 
end I used the SNP frequency of each of the pooled samples at each CRISPR 
targeted site across the ancestral genome (Fig. 2) to calculate the genetic 
distance from the ancestor of each sample. 
 
 
In accordance with theory increasing the CRISPR allele diversity of a host 
population reduces the likelihood that phage will be able to become locally 
Figure 4. Phage evolved on less diverse host populations are more genetically 
distant from the ancestral phage 
Bars show average change relative to the ancestral phage genome across all target 
sites in the ancestral virus genome and in the genomes of virus from pooled samples 
of all biological replicates from a single diversity treatment, error bars show 95% 





adapted to that population (175), and that phage which do become locally 
adapted are likely to be more genetically diverse as a result of selection on their 
genomes through CRISPR-cas targeting.  An ANOVA revealed an interaction 
between the number of unique hosts in the population and the amount of genetic 
change phage underwent during evolution on the different host populations (F3,184 
= 94.18, p < 0.0001). 
 
Another way to evaluate the evolutionary effect of varying CRISPR allele diversity 
in a host population on phage is to use a diversity metric to quantify levels of 
genetic diversity. Using a gini-Simpson’s index on the phage SNP data shown in 
Fig. 2 I calculated levels of evolved phage diversity to allow me to compare them 
with host diversity data from Fig. 1 and local adaptation data from Fig. 3. Given 
that the SNP data comes from pooled samples we assume that there is no 








Using the gini-simpson’s diversity metric I found that there was much more 
variation in the samples than when measuring change in phage populations as 
the genetic distance from ancestor (Fig. 4), this is likely due to significant 
polymorphisms in a few samples. However, the number of unique hosts in the 
population still has an effect on the amount of genetic diversity in evolved phage 
(ANOVA, F3,184 = 81.99, p < 0.0001). Since the two measures of change in 
evolved phage (distance from ancestor and genetic diversity) show the same 
trend but with different patterns of variation I use both of these metrics in the 
following figures where I investigate the relationship between changes in evolved 
phage and other variables. 
 
CRISPR allele diversity effects on local adaptation 
In the first of my comparisons of the new data I have generated I used the 
reanalysed data from my work with van Houte et al (35), which accounted for 
duplicate BIMs in the population, and plotted this against my re-analysis of the 
prevalence of local adaptation from my work with Morley (165). This allowed me 
to investigate the relationship between host population CRISPR allele diversity 
and phage local adaptation to host populations. 
 
 
Figure 5. Phage evolved on less diverse host populations are more 
genetically diverse 
Bars show average gini-simpson’s diversity score of evolved phage SNP 
frequencies shown in Fig. 2 across all target sites in the genomes of virus from 
pooled samples of all biological replicates from a single diversity treatment, error 
bars show 95% confidence intervals (monocultures: n=48; 6-clone: n=8; 12-clone: 







In agreement with previous work (165) I find that as the number of unique spacers 
in the host population increases the rate of phage local adaptation decreases 
(Nonlinear regression: p < 0.001, F1,59 = 362.9, R2 = 0.5526). I next wanted to 
investigate how becoming locally adapted affected the phage populations on a 
genetic level in order to understand the relationship between genetic change and 
local adaptation.  
 
 
Figure 6. Local adaptation decreases as host diversity increases 
Nonlinear regression: Line shows second order polynomial, points show mean 
number of BIMs in host population plotted against mean local adaptation score for 
each SNP site (Fig. 2), error bars show 95% confidence interval. (monocultures: 




The importance of host diversity in phage adaptation 
In the original data from van Houte et al (35) host diversity treatments were split 
categorically into 1, 6, 12, 24 and 48 unique CRISPR spacers. It was assumed 
that all spacers were unique, however sequencing revealed that some duplicate 
spacers were present. Here I use data in which I have corrected for the selection 
bias on protospacers in phage genomes caused by duplicate spacers within 
diversity treatments and used the average numbers of unique spacers in each 
group to quantify host diversity. To compare how genetic change in phage was 
affected by the number of CRISPR alleles in a host population I plotted phage 
adaptation (as measured by distance from ancestor (Fig. 7A) or by phage genetic 








Supporting the findings of van Houte et al (35) I find that phage which were 
evolved with fewer unique CRISPR alleles in the host population are more 
genetically distant from the ancestral phage (Fig. 7A, non-linear regression, F1,59 
= 76.95, R2 = 0.2224, p < 0.001) and that evolved phage diversity decreases with 
increasing host diversity (Fig. 7B, non-linear regression F1,59 = 5.64, R2 = 
0.00987, p = 0.0208). This fits with the findings of Morley et al (165) who showed 
phage are more able to become locally adapted to host populations containing 
fewer CRISPR alleles and highlights the importance of both host and parasite 








Figure 7A. Phage become more genetically distant from the ancestral phage 
as local adaptation increases 
Nonlinear regression: Line shows second order polynomial, points show mean 
number of BIMs in host population plotted against mean genetic distance from 
ancestor, error bars show 95% confidence interval. (monocultures: n=48; 6-clone: 
n=8; 12-clone: n=8; 24-clone: n=6). 
Figure 7B. Phage adaptation decreases with increasing host diversity 
Nonlinear regression: Line shows second order polynomial, points show mean 
number of BIMs in host population plotted against mean evolved phage diversity at 
each SNP site, error bars show 95% confidence interval. (monocultures: n=48; 6-









I found that the relationship between local adaptation was not significant with 
phage genetic change measured either by distance from ancestor (Fig. 8A, non-
linear regression, F1,59 = 0.94, R2 = 0.58, p = 0.3356) or by phage diversity score 
(non-linear regression, F1,59 = 0.1028, R2 = 0.58, p = 0.7497). This is surprising 
since earlier analyses show a relationship between host diversity and the 
resulting diversity in evolved phage populations (Fig. 7), and that phage local 
adaptation correlates with host diversity (Fig. 6).  
 
Figure 8A.  
Nonlinear regression: Line shows second order polynomial, points show mean 
phage genetic distance from ancestor for each SNP site plotted against the mean 
local adaptation, error bars show 95% confidence interval. 
Figure 8B. 
Nonlinear regression: Line shows second order polynomial, points show mean 
phage genetic diversity score for each SNP site plotted against the mean local 





Here I investigate how host diversity affects phage evolution and local adaptation, 
van Houte et al (35) showed that the ability of CRIPSR-Cas to generate host 
genetic diversity limits the emergence of escape virus and present data which 
indicate population-level selection may have contributed to the evolution of 
CRISPR-Cas. In agreement, Morely et al (165) examined the effect of host 
diversity on the likelihood of infecting phage populations becoming locally 
adapted and found that increasing CRISPR allele diversity reduced the ability of 
phage populations to successfully infect and become locally adapted to host 
populations.  In this chapter I have collated and reanalysed data from both these 
papers in order to investigate the relationship between host CRISPR allele 
diversity and phage adaptation in more detail. My novel analyses confirmed that 
the previous findings of van Houte et al (35) and Morley et al (165) were robust 
to the changes in host diversity controlled for here. Additionally, I show that 
evolution on host populations containing increasing CRISPR allele diversity 
results in lower phage genetic diversity and fewer mutations acquired when 
compared with the ancestral virus in evolved phage populations following 
exposure to host populations with increasing CRISPR allele diversity. I found that 
the rate of phage local adaptation did not correlate with the amount of evolved 
phage diversity, or distance from the ancestral phage.  
 
Theoretical studies predict that when infections are specific, increased host 
genetic diversity reduces the severity of an epidemic by reducing the frequency 
of susceptible hosts to a phage genotype (166). Because infections of a non-
matching host genotype will result in parasite death parasite population sizes, 
and therefore evolutionary potential,  will be reduced, limiting parasite adaptation 
(35).  van Houte et al (35) showed that increasing CRISPR allele diversity 
reduced the ability of phage to replicate on host populations, this likely explains 
my finding that increasing host CRISPR allele diversity decreases the ability of 
phage populations to evolve (measured as the distance of the evolved phage 
from the ancestral phage), limiting the diversity of the phage population, and 
therefore the evolutionary potential. It is often assumed that specificity in host-
parasite interactions results in local adaptation. This is because parasites can 
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drive diversification of host genotypes across time and space, which in turn 
selects for different parasite genotypes (177, 178) and the degree of local 
adaptation is expected to increase with the strength of selection imposed by the 
parasite (172). While I was unable to detect a significant relationship between 
phage genetic diversity and rates of local adaptation the analyses presented here 
show a strong relationship between host diversity and phage adaptation. 
Increasing host diversity decreases the ability of phage to evolve, and therefore 
the evolutionary potential of the phage population to become locally adapted. 
Previous work has shown that infection with diverse phage can drive the evolution 
of diversification of CRISPR alleles within host populations (43). The experiments 
described above used clonal phage stocks in order to specifically examine the 
effects of host diversity, it is possible that if the infecting phage population 
harboured pre-existing diversity within the protospacer or PAM sequences 
targeted by the host populations CRISPR-Cas system then successful infections 
are more likely, increasing parasite evolutionary potential, and promoting ongoing 
co-evolution (173). In combination with previous co-evolution data (136) and work 
investigating the effect of phage genetic diversity on the evolution of CRISPR-
Cas (43) the data presented here suggest that local adaptation may occur 
between phage and host populations with CRISPR-Cas under the right 
conditions, and genetic diversity of both host and parasite populations will be 
important factors in dictating whether or not local adaptation occurs and the 
outcome of such interactions,  however further studies are required to clarify this.   
 
The speed at which CRISPR based defence and escape phage can evolve under 
the right conditions indicates the potential for rapid local adaptation. A mechanism 
known as ‘priming’, whereby CRISPR-Cas systems can rapidly evolve high levels 
of CRISPR allele diversity, but only if the CRISPR-Cas system possesses a pre-
existing spacer in the CRISPR array which has partial complementarity to the 
phage (179–181) may indicate that local adaptation occurs in natural interactions 
between phage and hosts possessing CRISPR based immunity. Priming greatly 
accelerates the addition of novel spacers into the hosts CRISPR-array and 
therefore the number of phage genotypes which CRISPR-Cas can recognise and 
defend against. Because of the requirement for priming, CRISPR-Cas systems 
are much better in dealing with phages that are similar to those that have infected 
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before compared to novel phages. This suggests that in nature CRISPR-Cas 
systems may cause local adaptation of bacterial hosts (and therefore 
maladaptation of phage). Several metagenomic studies have shown that 
CRISPR spacers tend to match sympatric phage genomes rather than phages 
from foreign environments (182–186). Reinfection with these phages or 
genetically similar phages will trigger a strong CRISPR immune response to 
which the phage cannot adapt, whereas infection with phage from a foreign 
environment will not trigger a strong CRISPR immune reaction. The importance 
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CRISPR-Cas adaptive immune systems are found in bacteria and archaea and 
provide defense against phage by inserting phage-derived sequences into 
CRISPR loci on the host genome to provide sequence specific immunological 
memory against re-infection. Under laboratory conditions the bacterium 
Pseudomonas aeruginosa readily evolves high levels of CRISPR-based 
immunity against clonal populations of its phage DMS3vir, which in turn causes 
rapid extinction of the phage. However, in nature phage populations are likely to 
be more genetically diverse, which could theoretically impact the frequency at 
which CRISPR-based immunity evolves which in turn can alter phage persistence 
over time. Here we experimentally test these ideas and found that a smaller 
proportion of infected bacterial populations evolved CRISPR-based immunity 
against more genetically diverse phage populations, with the majority of the 
population evolving a surface modification preventing phage adsorption and 
providing generalised defence against a broader range of phage genotypes. 
However, those cells that do evolve CRISPR-based immunity in response to 
infection with more genetically diverse phage acquire greater numbers of 
CRISPR memory sequences in order to resist a wider range of phage genotypes. 
Despite differences in bacterial resistance evolution, the rates of phage extinction 
were similar in the context of clonal and diverse phage infections suggesting 
selection for CRISPR-based immunity or sm-based resistance plays relatively 
minor role in ecological dynamics in this study. Collectively, these data help to 
understand the drivers of CRISPR-based immunity and their consequences for 
bacteria-phage coexistence, and, more broadly, when generalised defences will 
be favoured over more specific defences. 
 
Introduction 
Bacterial and archaeal viruses can influence microbial communities both through 
direct interactions with their hosts as well as indirect effects on non-host 
populations (46, 47, 187, 188). The selective pressure of viral predation has 
resulted in the evolution of a range of archaeal and bacterial defence 
mechanisms, which includes CRISPR-Cas systems, prokaryotic argonautes, 
Restriction-Modification (R-M) systems, surface modification (sm), toxin-antitoxin 
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and Abortive Infection systems (69). These defences differ in multiple ways 
including the range of phage to which they provide resistance (generalist versus 
specialist) and in their fitness costs. (79). In bacteria two of these mechanisms, 
sm and CRISPR-Cas systems, are often found to be important for rapid evolution 
of phage resistance, with sm perhaps representing the simplest, and most 
common, line of defence by mutation of the bacterial cell surface, obscuring or 
altering the receptor that is used by the phage to attach to the cell (37). 
Alternatively, bacteria may employ their CRISPR-Cas (Clustered Regularly 
Interspaced Short Palindromic Repeats; CRISPR-associated) adaptive immune 
systems, which occur in approximately 30% of the bacterial genomes sequenced 
to date (78). Initially naïve bacteria acquire CRISPR-based immunity by 
incorporating nucleic acids from phage genomes into CRISPR loci on their own 
genome (107, 108), where they are known as “spacers” (109). Processed 
CRISPR transcripts guide Cas proteins to detect and destroy re-infecting phage 
that carry the cognate target sequence (110, 111). Phage can in turn overcome 
CRISPR-based immunity by acquiring a point mutation in the target sequence on 
their genome (106), although the emergence and spread of such phage “escape” 
mutants is constrained by both the diversity of CRISPR immunity alleles in the 
bacterial population and the fitness costs associated with the phage mutations 
(35, 112–114). 
While our mechanistic understanding of the different defence strategies of 
bacteria has raced ahead, the ecological conditions that favour one type of 
defence over another, and their consequences for the ensuing bacteria-phage 
population dynamics remain unclear (36, 79). Previous work has shown that the 
inducible cost of CRISPR-Cas means CRISPR-based immunity will typically be 
favoured over more costly constitutive defences, such as sm, under relatively low 
forces of infection (34). However, because the cost of sm-based resistance is 
fixed, it may provide a selective advantage when the force of infection is high. 
Given that the cost of sm-based resistance can increase in the presence of 
bacterial competitors, CRISPR-based immunity evolution may generally be more 
important in a microbial community context (133) .  
Here, we focus on another key distinction between the different types of defence: 
their different levels of specificity. CRISPR-Cas mediated defence is necessarily 
fairly specific, with a single spacer unlikely to be able to target all phage 
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genotypes within a population. While spacer diversity within bacterial populations 
provides an additional population level resistance by increasing the chance of 
phage extinction, this benefit may be reduced if phage populations are sufficiently 
diverse and hence there are variants that can escape targeting by many spacers. 
By contrast, sm-based resistance provides resistance against a broad range of 
phage genotypes, and typically requires multiple mutations for phage to 
overcome (104, 105, 189). We therefore hypothesised that increasing the 
diversity of infecting phage populations would increase selection for sm-based 
resistance. 
Here we test the effect of phage genetic diversity using P. aeruginosa PA14 and 
its phage DMS3vir. P. aeruginosa is an opportunistic human pathogen and a 
model organism for studying the mechanism and evolutionary ecology of 
CRISPR-Cas systems. P. aeruginosa PA14 can evolve resistance to the phage 
DMS3vir through either surface modification or CRISPR-Cas (34, 156). In order 
to directly test the impact of phage genetic diversity on the frequency at which 
CRISPR-based immunity evolves, we generated phage DMS3vir populations 
with increased genetic diversity by serial passage of the phage on a phage-
sensitive Pseudomonas aeruginosa PA14 derived strain. We then exposed the 
bacterium Pseudomonas aeruginosa strain PA14 to the genetically more diverse 
populations of the phage DMS3vir, or to a clonal phage DMS3vir population. 
Following infection with genetically diverse phage populations, a smaller 
proportion of the initially phage-sensitive bacterial populations relied on CRISPR-
based immunity. Moreover, those bacteria that relied on CRISPR-based 
immunity in the face of diverse phage populations acquired more spacers per 
individual compared to those that were exposed to clonal phage populations, 
presumably because this allows them to resist a wider range of phage genotypes 
(35, 164). The ultimate effect of the frequency of CRISPR-based immunity on the 
rate of phage extinction was however independent of the levels of standing 








Bacterial strains and phages 
P. aeruginosa UCBPP-PA14 (referred to as WT, carrying no spacers with a 
perfect match to the DMS3vir genome), P. aeruginosa UCBPP-PA14 csy3::LacZ 
(156) (referred to as CRISPR-KO, since it carries a disruption of an essential cas 
gene that causes the CRISPR-Cas system to be non-functional), and P. 
aeruginosa UCBPP-PA14 mutS::MAR2xT7 (190), which was kindly provided by 
Alexandro Rodriguez Rojas (below this strain is also referred to as a mutator 
strain of PA14), and the CRISPR-KO-derived surface mutant (sm) (described 
previously in ref. (34)), were used in all experiments. The obligately lytic phage 
DMS3vir was used in all experiments, and has previously been described in 
(156). All statistical analyses were carried out in R version 3.4.4. 
 
Generating Diversity within Phage Populations 
To generate genetically diverse populations of phage DMS3vir, the phage was 
amplified on P. aeruginosa UCBPP-PA14 mutS::MAR2xT7, a transposon mutant 
of P. aeruginosa that lacks the mutS gene. No DNA-polymerase has been 
characterized on the DMS3vir genome so we hypothesized that replication on a 
mutator strain of its host would result in increased levels of genetic variation within 
the phage population. Bacteria and phage were grown in 10ml LB media, by 
inoculating 1:100 from an overnight culture of P. aeruginosa UCBPP-PA14 
mutS::MAR2xT7 and subsequent infection with 106 pfu (plaque forming units) of 
DMS3vir. 12 independent cultures were inoculated, followed by incubation at 
37oC while shaking at 180 rpm. After 24h phage were sampled via chloroform 
extraction by mixing the overnight cultures 2:1 with chloroform followed by 
vortexing and centrifugation at 3500 rpm to pellet bacterial debris. Supernatant 
containing phage was stored at 4oC and used to infect naïve P. aeruginosa 
UCBPP-PA14 mutS::MAR2xT7 cells in fresh media, as described above. This 
procedure was repeated daily for 17 days, resulting in phage populations with 
increased levels of genetic diversity. We then generated derived clonal 
populations by isolating a single phage clone from each of the twelve diverse 
populations, using double plaque purification, followed by a single round of 
amplification on P. aeruginosa UCBPP-PA14 csy3::LacZ bacteria. 
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Deep sequencing of phage populations  
To measure the levels of standing genetic variation in the diverse and derived 
clonal phage populations that were generated as described above, we extracted 
phage DNA from approximately 108 - 109 pfu using the Norgen phage DNA 
isolation kit, following the manufacturer’s instructions. After QC with Nanodrop, 
Qubit and electrophoresis to quantify the amount and quality of extracted 
material, the extracted DNA was sequenced using MiSeq by the Liverpool Center 
for Genomic Research, using previously described protocols (35). Ancestral virus 
was processed in parallel as a control for SNP calling. Barcoded Illumina Truseq 
Nano libraries were constructed from each DNA sample with an approximately 
350 base insert size and 2×250 base reads generated on an Illumina MiSeq 
platform. Reads were trimmed for the presence of Illumina adapter sequences 
using Cutadapt version 1.2.1 and Sickle version 1.200 with a minimum window 
quality score of 20. After trimming most reads were around 250 bases and reads 
shorter than 10 bases were removed. Overlapping reads were joined using Flash 
version 1.2.8 to create high quality sequence at approximately 8,000x coverage 
of DMS3vir per sample. Reads from evolved phage populations were mapped to 
the ancestral DMS3vir genomes using bwa mem version 0.7.12. Sites which had 
coverage lower than 100 and an alternate allele frequency of >0.005 in the 
ancestor were filtered out to minimise sequencing error and noise. Data for SNPs 
which were fixed (>0.95 frequency) in any of the clonal population samples was 
extracted. No fixed mutations were found in the diverse populations that were not 
present in one of the clonal populations. Sequence data have been deposited in 
the European Nucleotide Archive under accession number ENA: PRJEB31472 
 
Infectivity of genetically diverse phage on CRISPR resistant bacteria  
We investigated the effect of phage genetic diversity on the ability of the phage 
population to overcome CRISPR targeting by testing the 12 experimentally 
evolved phage populations for infectivity against 12 CRISPR-immune bacteria. 
The bacteria used for infectivity tests were obtained from previous co-evolution 
experiments with DMS3vir. The selected isolates have been sequenced to 
ensure each was carrying a unique single spacer sequence (35). The infectivity 
of phage was determined by spot assay on a lawn of each of the CRISPR-
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immune bacteria and the CRISPR-KO strain (which carries an inactive CRISPR-
Cas system and is therefore sensitive to phage infection). Infectivity is expressed 
as the Efficiency of Plaquing (EOP) on the CRISPR immune host, which was 
calculated by dividing the PFU/ml formed by the phage population on the relevant 
CRISPR-immune bacteria by the PFU/ml formed on the CRISPR-KO strain. 
Additionally, we tested all phage populations’ infectivity against 6 CRISPR-
immune bacterial strains each carrying 2 spacers, and against one strain with 
sm-based resistance. 
 
Measuring the Effect of Diversity on Phage Persistence  
To investigate how genetic diversity within a phage population affects the phage 
population dynamics we inoculated 6ml M9 media supplemented with 0.2% 
glucose 1:100 with WT cells and added 104 pfus of either clonal or diverse phage. 
Phage titers were measured after 1, 3 and 5 days: Phage were extracted using 
chloroform as described above and a dilution series was spotted on a lawn of soft 
LB (0.5% agar) inoculated with P. aeruginosa PA14 csy3::LacZ to quantify phage 
titers. 
 
Effect of phage diversity on CRISPR-based immunity evolution 
To investigate how the diversity of an infecting phage population affects the 
evolution of resistance mechanisms in the host we co-cultured WT P. aeruginosa 
UCBPP-PA14 with either clonal or diverse phage for 3 days. Glass vials were 
filled with 6 ml of M9 media supplemented with 0.2% glucose and inoculated with 
106 cfu/ml of P. aeruginosa and 104 pfu of phage from one of either the diverse or 
clonal populations (n=8) then incubated for 24h (+/-3h) at 37oC while shaking at 
180 rpm. Transfers to fresh media were performed daily at a concentration of 
1:100. The bacterial populations were sampled at 3 dpi (days post infection) and 
resistance profiles of the bacterial isolates from the experimental populations 
were determined via streak assays against either ancestral phage (DMS3vir) or 
the isogenic phage DMS3vir-AcrIF1, which carries an antiCRISPR (Acr) gene that 
blocks the CRISPR-Cas system of P. aeruginosa UCBPP-PA14 (176). Lines of 
phage were applied to agar plates and allowed to dry for 20 minutes. Bacterial 
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colonies were streaked across the lines of phage and plates were incubated 
overnight at 37oC. Bacteria were scored to be CRISPR immune when they were 
resistant to DMS3vir, but not to DMS3vir-AcrIF1 (also associated with a motile, 
swarming phenotype) and surface-based resistance was scored when they were 
resistant to both phages (also associated with a smooth, non-motile phenotype). 
Bacteria were scored to be sensitive when they displayed resistance to neither 
phage. Additionally, evolution of CRISPR-based immunity was further confirmed 
by PCR of both CRISPR loci, using primer pairs 5’-
CTAAGCCTTGTACGAAGTCTC-3’ and 5’-
CGCCGAAGGCCAGCGCGCCGGTG-3’ to determine spacer acquisition at the 
CRISPR 1 locus, and primer pairs 5’-GCCGTCCAGAAGTCACCACCCG-3’ and 
5’-TCAGCAAGTTACGAGACCTCG-3’ to determine spacer acquisition at the 
CRISPR 2 locus. 
 
Results 
Diverse phage populations harbour more SNPs 
Given the sequence specificity of CRISPR-based immunity against phage, we 
hypothesised that phage genetic diversity will constrain the evolution of CRISPR-
based immunity relative to sm-based resistance, with potential knock-on effects 
for phage persistence. To test this, we amplified phage DMS3vir on a mutator 
strain of P. aeruginosa PA14 with the aim of increasing phage genetic diversity. 
After 17 passages of DMS3vir on the mutator strain, we performed deep 
sequencing analysis on the phage populations to examine if the standing levels 
of genetic diversity (i.e. SNPs frequency) were increased relative to paired clonal 
control populations that were derived from each of the diverse populations.  
Although the sensitivity of deep sequencing is insufficient to identify rare 
genotypes, it revealed 40 SNPs across the 16 phage populations (8 “clonal” and 
8 “diverse”) which were present at 0.01% frequency or higher after processing to 
remove sequencing noise and error. All of the SNPs found in clonal populations 
were also present in the paired diverse population. Based on this analysis, 
diverse populations were found to contain an average of 9.2 SNPs (ranging from 
5-13 in each population), while clonal populations were found to only have an 
average of 3 SNPs (ranging from 1-4). However, SNP frequencies based on deep 
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sequencing analysis inevitably underestimate the true level of genetic variation in 
the populations as rare alleles are filtered out to limit the noise from sequencing 
errors. Nonetheless, a Kruskal-Wallis test confirmed that the diversified phage 
populations had a higher average SNP frequency than the paired clonal strains 
(Figure 1A) (x2(2) = 11.94, p<0.001), and most SNPs were located close to gene 
42, which contains a CRISPR priming site (34), which suggests that the observed 
SNP clustering may result from acquisition of spacers from this area of the phage 
genome and subsequent evolution of escape by the phage during the passaging 
on the mutator strain.   
 
Genetically diverse phage are more infective on hosts with CRISPR-based 
immunity 
Previous work has shown that point mutations in the phage genome sequence 
that is targeted by the CRISPR-Cas immune system often allows the phage to 
by-pass this defence (35, 106, 161, 165). We therefore predicted that the 
genetically more diverse phage populations would have greater infectivity on 
bacteria with CRISPR-based immunity compared to their paired clonal phage 
populations or the ancestral population. Given that it is much harder for phage to 
evolve to recognize a novel receptor (189), we expected that the levels of 
infectivity of the diversified and clonal phage populations would be the same on 
a bacterium with sm-based resistance. To test these ideas, we examined the 
levels of infectivity for each of our diversified and clonal populations against 12 
clones with CRISPR-based immunity of P. aeruginosa PA14, each possessing a 
single unique spacer, and against 6 clones with CRISPR-based immunity each 
carrying two spacers targeting DMS3vir, which is harder to overcome by point 
mutation (35, 164), as well as a PA14 strain with sm-based resistance. As 
expected, we found that infectivity of genetically more diverse phage populations 
was higher on bacteria with CRISPR-based immunity than that of clonal phage 
populations (Wilcoxon Signed Rank Test, W=1359, Z=-9.5082, p<0.0001), but 
neither of the phage populations were infective against hosts with 2 spacers or 
sm-based resistance (Figure 1B). Consistent with the idea that SNPs are present 
at a low frequency in the phage population, the EOP of more genetically diverse 
phage was typically around 10-5 for each spacer tested, an increase of around 
10-200 fold compared with the clonal phage populations. Collectively, these data 
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support the idea that phage diversified during the repeated amplification on the 





Figure 1  
 
 
Type of evolved host resistance depends on the levels of phage genetic 
diversity 
In order to study if and how phage genetic diversity impacts the frequencies of 
CRISPR and sm-based resistance that evolve in the bacterial population 
following infection, we performed an evolution experiment and monitored the 
phage population dynamics as well as the levels of CRISPR-based immunity 
observed following infection of WT PA14 with the clonal or more genetically 
Figure 1. Our 12 evolved phage populations harbour greater genetic variation 
than the derived clonal populations. A) The frequency of SNPs in diverse (purple) 
phage populations (N=12) and clonal (blue) (N=12) populations. B) The average 
efficiency of plaquing of our 12 experimentally evolved diverse phage 
populations, or the 12 derived clonal phage populations on each of 12 CRISPR-
resistant Bacteriophage Insensitive Mutants (BIMs). Each BIM carries a single 
unique spacer targeting the ancestral phage. infectivity of phage populations was 
also tested against 6 BIMs carrying 2 spacers targeting the ancestral phage (this 
data is shown as one bar as no escape mutants were identified against any of 
the 6 clones possessing 2 spacers each) and a surface mutant (sm). All graphs 
show averages and error bars represent 95% confidence intervals.  
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diverse phage DMS3vir populations. Consistent with previous studies (34, 35), 
we found that phage titres increased in all replicates following infection of the WT 
strain, which is expected given that bacteria are initially sensitive to the phage. 
However, from 1 days post infection (dpi) onwards, phage titres started to decline 
until complete extinction at 6 dpi, with no clear difference between the diversified 
and paired clonal phage populations (Figure 2A, ANOVA, F(1,22)=0.02, p>0.8). 
However, analysis of individual bacterial clones that were isolated at 3 dpi 
revealed clear differences in the frequencies of CRISPR-based immunity and sm-
based resistance that had evolved following infection with genetically diverse or 
clonal phage populations (Figure 2B, ANOVA, F(2,1)= 54.72, p<0.0001). 
Specifically, we found that the frequency of sm-based resistance was higher in 
populations challenged with a genetically more diverse phage population than in 
populations challenged with the paired clonal population (Post hoc analysis with 
Tukey HSD, p<0.0001), and this was associated with a corresponding decrease 
in the frequency of CRISPR-based immunity (p<0.0001) (Figure 2B). These data 
therefore show that increasing phage genetic diversity can cause a decrease in 
the frequency at which CRISPR-based immunity evolves and a corresponding 
increase in the frequency at which sm-based resistance evolves.  







Bacteria evolving CRISPR-based immunity against genetically diverse 
phage carry more spacers 
Given that the number of spacers targeting a phage within a single host 
influences the propensity of phage to overcome CRISPR-based immunity (Figure 
1B and (35, 164)), we also examined how genetic diversity within infecting phage 
populations affects the number of spacers that individual bacterial clones acquire. 
PCR analysis of the CRISPR loci of bacterial clones following exposure to either 
the genetically more diverse phage DMS3vir populations or the paired clonal 
controls revealed that the patterns of spacer acquisition in cells using CRISPR-
based immunity differed depending on the genetic diversity of the phage they 
were infected with (Figure 3B). Specifically, upon infection with clonal phage the 
majority of cells which had acquired CRISPR-based immunity had acquired only 
one spacer (Figure 3A, Tukey HSD, p<0.005), whereas upon infection with 
genetically more diverse phage the majority of cells which had acquired CRISPR-
based immunity had acquired multiple spacers (Tukey HSD, p<0.05). Despite 
differences in the patterns of spacer acquisition, analysis with ANOVA revealed 
the average total number of spacers per clone gained was not affected 
(F(1,14)=7.42, p>0.1) (Figure 2C). Collectively, the higher proportion of bacteria 
with sm-based resistance or CRISPR-based immunity with multiple new spacers 
in response to infection with genetically more diverse phage suggests selection 
for more generalist defence mechanisms under those conditions.  
Figure 2. No effect of phage genetic diversity on phage persistence. A) 
Phage titers (PFU/ml) over time following infection of WT bacteria with a 
genetically diverse or a derived clonal phage population. Each line represents 
a single replicate. B) The average proportion of cells at 3 dpi that evolved 
CRISPR-based immunity (purple), surface modification (sm) based 
resistance (orange), or that remained sensitive (green) and C) the average 
number of spacers acquired by each CRISPR clone in response to infection 
with clonal (blue) or diverse (purple) phage. All graphs show averages and 
error bars represent 95% confidence intervals. Individual data points are 
indicated with dots, and numbers next to the dots indicate the number of 
replicates in which the same value was observed. 
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Here, we tested whether increasing genetic diversity within a parasite population 
will increase selection for generalist over specific immune defences. We find that 
infecting P. aeruginosa with experimentally evolved populations of phage 
DMS3vir that have elevated levels of standing genetic diversity results in, first, 
higher frequencies of sm-based resistance compared with CRISPR-based 
immunity and that, second, cells with CRISPR-based immunity are more likely to 
acquire multiple spacers. Interestingly no difference in phage persistence 
between populations that were infected with clonal or genetically more diverse 
Figure 3. Patterns of spacer acquisition differ in response to infection with 
clonal or diverse phage. A) Average proportion of CRISPR clones in a 
population which acquired single or multiple spacers when infected with clonal 
(blue) or diverse (purple) phage. B) Average proportion of CRISPR clones in a 
population which acquired 1,2,3,4 or 5 spacers when infected with clonal or 
diverse phage. All graphs show averages and error bars represent 95% 
confidence intervals. Individual data points are indicated with dots, and 
numbers next to the dots indicate the number of replicates in which the same 
value was observed. 
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phage populations were observed. These data show that genetic diversity has an 
important effect on the frequencies of CRISPR-based immunity (specialist 
defence) and sm-based resistance (generalist defence) in this system. While the 
elevated genetic variation of phage DMS3vir is presumably more reflective of 
natural environments compared to the clonal phage populations that are typically 
used in experimental evolution studies,  it should be noted that our experiments 
do not capture the complexity of natural environments where different phages 
with overlapping host ranges tend to coexist, which can further impact the 
evolution of CRISPR-based immunity (191).   
CRISPR-Cas is a specific and adaptive immune defence that is widespread, yet 
not equally abundant in different ecosystems. Although CRISPR-Cas systems 
are found in a diverse range of habitats, there is a highly uneven distribution 
across different environments. Metagenomic sequence analyses have shown 
that the frequency of the evolution and maintenance of CRISPR-Cas systems in 
bacterial and archaeal communities may be linked to environmental factors as 
higher frequencies of CRISPR-Cas are often found in extreme environments 
(137–140).  This suggests that there are environmental attributes that constrain 
the fitness advantages (or ecological success) of this form of phage defence. 
Some of the earliest studies that looked at the ecological distributions of CRISPR-
Cas immune systems observed that these systems are overrepresented in high-
temperature environments, with thermophiles typically possessing more and 
longer CRISPR arrays (139, 192). Indeed, over 90% of hyperthermophilic 
archaea harbor CRISPR-Cas, and these environments are generally throught to 
be associated with moderate virus diversity (193). The ancestral primitive 
CRISPR-Cas systems likely evolved in archaea and were subsequently acquired 
by bacteria through horizontal transfer (194). It has been suggested that the 
prevalence of CRISPR-Cas in hyperthermophilic conditions may be due to lower 
mutation rates in those environments, which is supported by correlational and 
theoretical studies (137–140, 195). However, apart from accelerating the 
evolution of “escape” phage, high mutation rates will also increase the rate at 
which sm-based resistance evolves in the bacterial population, hence reducing 
the relative benefit of CRISPR-Cas immune systems (141). Here we teased these 
two effects apart by exposing bacterial populations to experimentally diversified 
or clonal phage populations of the phage DMS3vir. Our experimental data 
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support the idea that phage genetic diversity can tip the balance in the evolution 
of different defence strategies that bacteria employ to combat phage infections. 
Given that CRISPR-Cas immune systems are highly sensitive to the evolution of 
“escape” phage that overcome CRISPR immunity through mutation of their target 
sequences, greater levels of phage genetic diversity are likely to favour generalist 
defences that are more robust to phage evolution. Indeed, our experiments show 
that in this empirical system phage was unable to overcome sm-based 
resistance. Evolution of a novel receptor specificity would presumably require 
multiple adaptations in the phage tail fibres (189), and while this will occur in 
certain environments, the rate at which this happens will in most cases be low 
relative to the rate of CRISPR escape mutation. 
The results of this study highlight how ecological variables can drive the evolution 
of bacterial defence strategies and it will likely be important to consider phage 
genetic diversity when studying natural systems. For example, we may expect to 
find higher levels of viral genetic diversity, and therefore lower levels of CRISPR-
based immunity, in well-mixed environments such as in aquatic ecosystems, but 
the opposite may be true in systems with less migration, and therefore lower viral 
diversity, such as in soil. Environments associated with low viral mutation rates, 
as is often found in thermophilic microbial communities, will likely harbour higher 
levels of CRISPR-based immunity as generalist defences with a constitutive cost 
such as sm will have a selective disadvantage under these conditions. Biotic 
complexity is frequently ignored in laboratory evolution studies. It is also important 
to consider that in bacteria-phage interactions in natural ecosystems there will 
usually be a range of different phage types able to infect each host, and further 
work is needed to clarify how the presence of multiple phage would affect the 
evolution of bacterial resistance.  
Here we have shown that diversity in an infecting parasite population can impact 
the outcome of host-parasite interactions. In the data presented here our 
experimentally evolved phage were passaged on a mutant genotype of the same 
host used in our experiments. Therefore, the mutations acquired may not be as 
varied as when phage evolves on a range of hosts as will typically be the case in 
nature. The observed effects of intraspecific diversity (i.e. genetic diversity within 
the same species of phage) have been previously predicted by studies that 
modelled CRISPR-phage interactions (137),but as far as we are aware this is the 
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first work to demonstrate this experimentally. This work further contributes to our 
understand of the role of the CRISPR-Cas adaptive immune system in a microbial 
community context, and complements previous work on the role of bacterial 
diversity (133). Furthermore, this study suggests that genetic diversity is an 
important driver of when specific defences are favoured over generalist defences 
and should therefore be considered when investigating any host-parasite 
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Quorum sensing controls expression of a wide range of important traits in the 
opportunistic pathogen Pseudomonas aeruginosa, including the expression of its 
CRISPR-Cas immune system. This finding has led to the speculation that 
synthetic QS inhibitors could be used to limit the evolution of CRISPR immunity 
during phage therapy. Here we use experimental evolution to explore if and how 
a quorum sensing inhibitor influences the population and evolutionary dynamics 
of P. aeruginosa upon phage infection. We find that chemical inhibition of quorum 
sensing decreases phage adsorption rates due to downregulation of the Type IV 
pilus, which causes delayed lysis of bacterial cultures and favours the evolution 
of CRISPR immunity. Hence, our data show that inhibiting quorum sensing may 
reduce rather than improve the therapeutic efficacy of pilus-specific phages, and 




The increase in antimicrobial resistance has led to a resurgence of interest in 
phage therapy, where bacterial viruses (phage) are used to treat bacterial 
infections (196, 197). Pseudomonas aeruginosa is an important source of 
nosocomial infections and potential target for phage therapy (198). In the lab, 
bacteria tend to rapidly evolve resistance to phage (199), which in a clinical 
setting might limit the efficacy of the therapeutic application (42). Such rapid 
resistance evolution is mostly due to cell surface alterations that interfere with 
phage adsorption or due to the acquisition of CRISPR-based immunity, where 
bacteria insert phage-derived sequences into CRISPR loci on the host genome, 
which are used to detect and destroy the same phage during future infections. In 
the case of P. aeruginosa PA14, both these mechanisms of phage resistance 
have been shown to evolve at high frequencies in the lab, but the dominant 
mechanism depends on environmental variables, such as the microbial 
community context in which infections occur (133), the level of phage genetic 
variation (43), and the force of infection (43, 113, 133). The force of infection is 
an important determinant of CRISPR immunity evolution because unlike surface-
based resistance, which carries a fixed fitness cost, CRISPR immunity is 
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associated with an infection-induced fitness cost (34). Hence, in environments 
with a high force of infection, surface-based resistance is favoured by natural 
selection over CRISPR immunity and vice versa (34, 43, 113, 133). Because 
evolution of surface-based resistance, but not CRISPR immunity, is associated 
with virulence trade-offs (133), being able to manipulate which type of phage 
resistance evolves could have important clinical impact. 
One way to manipulate this in a clinical setting may be by applying Quorum 
Sensing (QS) inhibitors, since it was recently demonstrated that QS controls 
expression of the CRISPR-Cas immune system in P. aeruginosa (53) and in 
Serratia (195). QS is a well-studied bacterial communication system which allows 
bacteria to monitor local cell densities. In P. aeruginosa PA14 QS is carried out 
by two separate but interrelated pathways, known as lasR-lasI and rhlR-rhlI (200, 
201). Each system is comprised of a receptor and an autoinducer (AI); LasI 
produces the AI 3-oxo-C12-homoserine lactone (3OC12-HSL) which is bound by 
the LasR receptor. The LasR-3OC12-HSL complex activates expression of a 
wide range of target genes, including those required for virulence and biofilm 
formation. The LasR-3OC12-HSL complex also causes RhlI to produce the AI 
C4-homoserine lactone (C4-HSL), which binds to the receptor RhlR and activates 
a second wave of QS-induced gene expression (202, 203) (reviewed in (204, 
205)). Because QS controls such a broad range of genes, many of which may 
impact phage infection dynamics, it remains unclear what the net effect of QS 
inhibitors is on the efficacy of phage therapy. For example, the QS system of P. 
aeruginosa controls expression of both the CRISPR-Cas immune system and its 
Type IV pili, which serve as receptors for many Pseudomonas phages (206–
211). We therefore tested how inhibition of QS in P. aeruginosa PA14 impacts 
the ecological and evolutionary interaction with a pilus-specific phage, DMS3vir. 
Our data show that QS inhibition triggers phenotypic changes in the bacterial 
population that result in partial immunity to phage due to reduced adsorption to 
the host cells, and the resulting decrease in phage infection frequencies favours 
the evolution of CRISPR immunity over surface-based resistance. These data 
help to predict how manipulation of QS can impact the outcome of bacteria-phage 






Bacterial Strains and Phage 
We used P. aeruginosa UCBPP-PA14 (referred to as WT), P. aeruginosa 
UCBPP-PA14 cas7::LacZ  (referred to as CRISPR-KO, since it carries a non-
functional CRISPR-Cas system) (156), a previously described CRISPR-KO-
derived surface mutant (referred to as sm) (34), and P. aeruginosa Tn::pilA 
(referred to as pilA KO) (190), a CRISPR-Cas resistant isolate of P. aeruginosa 
UCBPP-PA14 possessing two spacers targeting the phage DMS3vir (referred to 
as BIM2 – Bacteriophage insensitive Mutant, previously described in (34)), as 
well as double synthase mutant strain of P. aeruginosa UCBPP-PA14, ΔlasI ΔrhlI, 
(referred to as QS mutant) (53). For all infection experiments we used the 
previously described mu-like phage, DMS3vir (156). 
 
Elastin Congo Red assay 
Elastase production is a well-established method for measuring the levels of 
quorum sensing via elastase production since elastase is a public good and the 
production of elastase is known to be controlled by quorum sensing (212). WT or 
the QS mutant were grown in growth media as indicated with or without QS AIs. 
Samples were transferred to fresh media at a 1:100 dilution every 24 hours for 3 
days. On the third day samples were taken, the OD600 was measured and 
samples were then centrifuged at 15,000xg for 15 minutes. Elastin Congo Red 
(ECR) buffer (100 mM Tris, 1 mM CaCl2, pH 7.5) was pre-warmed to 37 C before 
adding ECR powder 1:10 (w/v). For each sample 900µl ECR solution was added 
to a fresh 1.5ml Eppendorf, then 100µl of sample supernatant was added. 
Samples were incubated at 37 C for 4 hours. Eppendorfs were centrifuged at 
15,000xg to remove debris, and OD495 of the supernatant was measured. 
Elastase production per capita was calculated as OD495/ OD600.  
 
Motility Assays 
P. aeruginosa UCBPP-PA14 WT or the ΔlasI ΔrhlI QS mutant were streaked onto 
1.5% LB agar plates and grown overnight at 37oC. Liquid cultures were created 
by inoculating 6ml M9 media supplemented with 0.2% glucose and inoculated 
with either the WT or QS mutant and grown for 24h at 37oC, 180rpm. Swimming 
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ability was determined by touching a sterile tip to a streak of the WT or QS mutant 
then inserting the tip halfway through the agar of a 0.3% LB agar plate. Swarming 
assays were performed by spotting 5µl of undiluted liquid culture onto 0.5% agar. 
All motility assay plates were incubated for 24h at 37oC. Motility was measured 
as the diameter of bacterial growth in mm at the widest point which intersected 
the point of inoculation. 
 
Evolution experiments 
Infection experiments were carried out in glass microcosms containing 6ml of M9 
media with 0.2% glucose supplemented with 100µM Baicalein (Cayman 
Chemical) dissolved in DMSO, and 106 cfu/ml P. aeruginosa PA14 WT. The same 
experiment was carried out concurrently with the QS mutant in the presence or 
absence of 2 µM 3OC12-HSL and 10 µM C4-HSL (Sigma) dissolved in DMSO. 
Control treatments received the same amount of DMSO. Total amounts 1x104 
pfu of phage (low phage), 1x107 pfu (mid phage) or 1x109 pfu (high phage) were 
added at the same time as the bacteria. Microcosms were incubated at 37 ºC 
while shaking at 180 rpm. Every 24 hours microcosms were sampled and 
transferred to fresh media at a 1:100 dilution. Samples from the infected cultures 
were taken prior to each transfer and chloroform treated to kill bacteria as 
described previously (35). 5µl of a serial dilution of chloroform treated sample 
was spotted onto a lawn of sensitive bacteria (PA14 CRISPR-KO strain). Plaques 
were counted and densities were calculated as plaque forming units/ml (pfu/ml). 
Bacteria were sampled at 3 days post infection to analyse the resistance 
mechanisms that evolved in response to phage infection.  
 
Resistance mechanism analysis 
To determine whether bacteria had evolved resistance, and whether this was 
surface-based resistance or CRISPR-based immunity, we performed cross-
streak assays as described previously (34). Briefly, clonal bacterial colonies were 
isolated by plating on LB agar, 24 colonies per replicate were picked at random 
per replicate, grown overnight in M9 media supplemented with 0.2% glucose and 
then streaked across either the ancestral phage (DMS3vir), or DMS3vir-acrIF1 
described in (35), which carries the anti-CRISPR gene acrIF1 that effectively 
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blocks the CRISPR-Cas immune systems of P. aeruginosa PA14 (35, 213, 214). 
Colonies which were resistant to the ancestral phage but not the phage carrying 
an anti-CRISPR gene were classed as CRISPR immune, whereas colonies that 
were resistant against both DMS3vir and DMS3vir-acrIF1 were classed as having 
sm (surface mutation) resistance. Colonies that were not resistant to either phage 
were classed as sensitive. Results were confirmed with PCR of both CRISPR loci 
to check for spacer acquisition as described previously (34). 
 
Competition experiments 
We measured fitness by competing the BIM2 targeting DMS3vir against either 
the phage-sensitive CRISPR-KO strain or against the phage-resistant surface 
mutant (the pilA KO or sm strain). A CRISPR immune strain with 2 phage-
targeting spacers was used to avoid confounding effects from the evolution of 
“escape phage” that carry mutations in their target sequences (35, 164). 
Competitions were performed in glass microcosms containing 6ml of M9 media 
with 0.2% glucose, and containing either the inhibitor (100µM Baicalein), the 
autoinducers (2 µM 3OC12-HSL + 10 µM C4-HSL), or both the QS inhibitor and 
inducer at these same concentrations. Controls contained the same volume of 
DMSO only. Microcosms were then inoculated with 106 cfu/ml of a 1:1 mix of the 
relevant bacteria. Cells were infected with 106 pfu/ml of phage DMS3vir. Vials 
were incubated at 37 ºC while shaking at 180 rpm for 24 hours and then sampled. 
The relative frequencies of each strain were determined via serial dilution and 
plating on 1.5% LB agar plates containing 50 mg ml-1 X-gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside). Relative fitness was calculated as (rel. fitness = 
[(fraction strain A at t=x) * (1 – (fraction stain A at t=0)) ] / [(fraction strain A at t=0) 
* (1 – (fraction strain A at t=x)]). 
 
Phage adsorption 
WT P. aeruginosa was grown for 24 h in media supplemented with either DMSO 
(control) or the QS inhibitor. Cultures were centrifuged at 3500 rpm to form a 
pellet. The supernatant was discarded and the pellets were resuspended in 5ml 
of pre-heated (37 oC) medium with or without the QS inhibitor to OD600 0.2. 
Cultures were incubated at 37 oC, 180 rpm for 3 hours to achieve mid-log phase 
and then diluted to a final volume of 15ml. 6 ml of each sample was taken and 
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stored on ice. The remaining 9 ml was put back in the incubator at 37 oC, 180 
rpm. One tube of plain growth media was also processed as a control. Cultures 
were incubated for 5 minutes to allow for temperature equilibration. 1 ml of pre-
warmed phage in growth media was added to each culture with a final 
concentration of 2 x 105 pfu/ml. Cultures were mixed and a sample taken and 
added to Eppendorf vials containing 100µl of chloroform, and stored on ice in an 
insulated box. This process was repeated at 3, 6, 9, 12, 15, 20, 25, 30, 40 and 50 
minutes post infection. Phage densities were calculated via chloroform extraction 
and  by spotting virus samples isolated by chloroform extraction on a lawn of 
CRISPR KO bacteria. Bacterial densities were determined by plating dilutions of 
the original cultures on LB Agar plates and counting CFUs. The fraction of free 
phage particles at each time point were calculated relative to the phage titre at 
T0 by taking the average PFU/ml of 3 replicates at each time point and calculating 
the % of remaining phage this value represented relative to it’s starting frequency 
using the formula:  
((Average PFU/ml at time X) x 100 / Average PFU/ml at T0) 
 
Phage removal assays 
To measure CRISPR-mediated phage removal over longer timespans, we mixed 
the BIM (BIM2) targeting DMS3vir with DMS3vir in glass microcosms containing 
6ml of M9 media supplemented with 0.2% glucose or DMSO with or without a QS 
inhibitor (100µM Baicalein) or QS AIs (2 µM 3OC12-HSL + 10 µM C4-HSL) and 
inoculated with 106 cfu/ml of the BIM. Cells were then infected with 106 pfu/ml of 
phage DMS3vir. Vials were incubated at 37 ºC while shaking at 180 rpm for 24 
hours and then sampled. Phage titres were determined via chloroform extraction 
and spot assay, as described above. 
 
Results 
The finding that QS controls expression of the Type IF CRISPR-Cas immune 
system of P. aeruginosa PA14 has led to the suggestion that QS inhibitors and 
phage may provide synergistic efficacies when applied together in a clinical 
context, due to more limited evolution of CRISPR immunity against the phage 
(53). To measure whether chemical QS inhibitors can limit the evolution of 
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CRISPR-based immunity against a pilus-specific phage, we exposed WT PA14 
to either 104, 107 or 109 pfu of phage DMS3vir in the presence or absence of 




In our control (WT supplemented with DMSO) evolution of CRISPR-based 
immunity decreased (and resistance via surface modification (sm) increased) 
with increasing phage titer, as reported previously (34). However, when QS 
inhibitors were added, we observed changes in the patterns of phage resistance 
evolution that were contrary to our expectation of a general reduction in CRISPR-
mediated immunity.  
Specifically, there was a significant increase in the persistence of phage-sensitive 
bacteria during infection with 104 pfu (U = 3, p < 0.05) or 107 pfu (U = 1, p < 0.01) 
of DMS3vir. This was associated with a reduction in the evolution of CRISPR 
immunity upon infection with 104 pfu of phage (U = 0, p < 0.01), or a reduction in 
Figure 1. Inhibiting QS results in reduced phage sensitivity and prolonged phage 
persistence at low phage densities. A-C) Observed resistance mechanism 
evolution in P. aeruginosa PA14 WT supplemented with DMSO (dark blue 
bars/points) or a QS inhibitor (light blue bars/points) and at 3 days post infection 
with A) 104 pfu B) 107 pfu C) 109 pfu of phage DMS3vir. Bars represent mean 
proportion of resistance mechanism evolution, error bars indicate 95% 








































sm resistance upon infection with 107 pfu of phage (U = 0, p < 0.01). The 
persistence of sensitive bacteria was no longer observed when bacteria were 
infected with 109 pfu of phage DMS3vir. Under those conditions, levels of CRISPR 
immunity were slightly higher compared to the control, and levels of sm resistance 
were slightly reduced. Further analyses revealed a significant interaction between 
QS inhibition and the evolution of CRISPR when infected with 104 (Z35,30 = -7, p 
< 0.0001), 107 (Z35,30 = 5.95, p < 0.0001), or 109 phage (Z35,30 = 7, p < 0.0001). In 
accordance with our finding that sm resistance is most affected at intermediate 
(107) levels of infection we find an interaction between QS inhibition and sm 
evolution when infected with 107 phage (Z35,30 = -2.02, p < 0.05) but not the lower 
(104) or higher (109) phage treatments. We were unable to detect any significant 
interaction between QS inhibition and the persistence of sensitive bacteria, 
consistent with the observed variance . As a control, we performed the same 
experiment using the QS mutant in the presence or absence of AIs and observed 




















A well-established method for quantifying QS activity is to measure elastase 
production since elastase production is known to be regulated by QS (212), to do 
this we used the Elastin Congo Red assay (212). This showed that the QS mutant 
produced significantly less elastase per capita than WT cells (U = 0, p < 0.0001), 
as expected, and addition of QS AIs reinstated elastase production to WT levels 
in the QS mutant (U = 30, p > 0.3,  Fig. 3). This shows that QS controls previously 





Figure 2. No significant difference is found in resistance mechanism evolution or 
phage persistence between a QS mutant which is unable to produce QS 
autoinducers and the same QS mutant supplemented with artificial autoinducers 
A-C) Observed resistance mechanism evolution in P. aeruginosa QS mutant 
when supplemented with DMSO (light green bars/points) or a QS autoinducer 
(dark green bars/points) and at 3 days post infection with A) 104 pfu B) 107 pfu C) 
109 pfu of phage DMS3vir. Bars represent mean proportion of resistance 
mechanism evolution, error bars indicate 95% confidence interval, points 






We envisaged two possible reasons why in the presence of Baicalein the 
evolution of phage resistance might be reduced upon infection with 104 or 107 pfu 
of DMS3vir. First, it may be the case that phage amplification is less efficient in 
the presence of the QS inhibitor, resulting in weaker selection for resistance. 
Second, QS inhibition may cause cells to become intrinsically more resistant to 
phage, as a result of reduced expression of phage receptors if they are also 
regulated by QS (216, 217). Indeed, the T4P, which is the receptor of many 
Pseudomonas phages including DMS3vir, is known to be regulated by QS, and 
manipulation of QS can therefore affect phage sensitivity (206–211).  
To investigate the idea that QS inhibition reduced the rate of phage amplification 
we monitored the phage densities throughout the evolution experiment described 
above. This showed that in the presence of the QS inhibitor, phage amplification 
was higher than or equal to that observed in the control (Fig. 4), and reduced 
phage amplification can therefore not explain the results of this experiment.  
 
Figure 3. Addition of QS AI to media reinstates QS mutant to WT levels of elastase 
production. Bars represent mean elastase production per capita, error bars indicate 







Further analyses showed that addition of a QS inhibitor to WT PA14 cultures 
made a significant difference to phage dynamics when cultures were infected with 
Figure 4 Phage replicate more efficiently when QS is inhibited and force of 
infection is low. Phage densities were monitored during the evolution 
experiment and quantified at 3, 5 and 8dpi when initial infections were with 
A+D) 104 pfu  B+E) 107 pfu C+F) 109 pfu of phage DMS3vir. Phage persistence 
data was taken from the same experimental replicates as were analysed for the 
resistance mechanism graphs at the corresponding phage start density. Lines 
show individual replicates, N = 6.  
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104 phage (F3,42 = 3.72, p < 0.05), but we could not detect a significant difference 
as phage titer increased to 107 (p > 0.1), or 109 PFUs (p >0.9). Similarly we found 
an effect on phage dynamics of adding a QS autoinducer to cultures of the QS 
mutant when infected with 104 PFUs (F3,42 = 3.52, p < 0.05), but not when infected 
with 107 (p > 0.9), or 109 PFUs (p > 0.9). Since we are able to detect differences 
in both resistance mechanism evolution (Fig. 1) and phage dynamics (Fig. 4) 
when QS is manipulated only when phage density is low supports the hypothesis 
that inhibiting QS causes bacterial cells to become intrinsically more resistant to 
phage infection. 
We next looked for phenotypic effects of QS inhibition which may help us to 
understand the mechanism responsible for the observed changes in resistance 
mechanism evolution (Fig. 1) and phage dynamics (Fig. 4). First we measured 
the impact of Baicalein on P. aeruginosa PA14 swarming motility, which is a Type 
IV pilus (T4P)-dependent and QS-regulated group behaviour (218–221). This 
analysis showed that the QS mutant was less able to swarm compared to WT 
cells (p < 0.0001) and that WT cells grown in the presence of the QS inhibitor 
Baicalein were no different in swarming ability to that of the QS mutants (p > 0.9) 
(Fig. 5A). As a control, we also measured swimming motility of the WT strain, 
which is known to be an individual behaviour not reliant on the T4P and QS (222). 
As expected, there was no significant effect of Baicalein on swimming motility in 
the WT and QS mutant strains (p > 0.1 in all cases) (Fig. 5B). Collectively, these 
data therefore confirm that QS inhibition using Baicalein inhibits a QS-controlled 








Next, we measured whether Baicalein affected phage adsorption. To this end, we 
infected WT P. aeruginosa PA14 cells in exponential growth phase with phage 
DMS3vir at an MOI of 0.01 and measured phage titers over 50 minutes in the 
presence or absence of Baicalein (Fig. 6A). This revealed a significant reduction 
in the rate of phage adsorption when the QS inhibitor was added to the media (T 
= 2.548, DF = 13.78, p > 0.05) supporting the hypothesis that QS inhibition leads 
to a reduction in phage adsorption.  
Based on previous work showing the CRISPR activity reduces phage densities 
because of the ability to continually remove phages from the population, we 
hypothesized that the intrinsic increase in resistance and associated reduction in 
CRISPR activity would result in higher phage titres. To test this hypothesis, we 
also measured phage titers after 24h of infection of CRISPR immune bacteria 
with 109 pfu of DMS3vir in the presence or absence of Baicalein or synthetic 
autoinducers (Fig. 6B). This revealed a significant decrease in the amount of 
Figure 5 QS inhibition reduces swarming but not swimming ability A) QS inhibition 
reduces swarming motility. B) QS inhibition has no effect on swimming motility. 
Bars represent mean growth in mm, error bars indicate 95% confidence interval, 
points represent individual replicates, N = 6. 
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phage removed in the presence of the QS inhibitor (U = 0, p <0.01) or the inhibitor 





Collectively, these data led us to predict that applying Baicalein may reduce the 
efficacy of phage-mediated killing by enhancing the intrinsic levels of phage 
resistance of the bacteria. To test this, we measured how Baicalein affects the 
fitness of phage sensitive bacteria in the presence of phage, by competing 
sensitive bacteria lacking a functional CRISPR-Cas immune system (CRISPR 
Figure 6. Phage are less able to infect hosts when QS is inhibited. A) Phage 
adsorption over time (3-50 minutes) when WT P. aeruginosa is infected with phage 
when supplemented with DMSO (control) (blue line) or the QS inhibitor (red line). 
Samples were taken at 3,6,9,12,15,20,25,30,40 and 50 minutes post infection. 
Lines represent % of free phage particles detected at each time point B) Titre of 
phage remaining at 24hpi of a CRISPR resistant host possessing two unique 
spacers targeting the infecting phage when initially infected with 109 phage. Bars 
represent mean titre of phage present at 24hpi, error bars indicate 95% confidence 
interval, points represent individual replicates, N = 6, Y axis is log10 scale. 
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KO strain) against a pilus deletion mutant (a pilA KO strain) that lacks the T4P 
providing complete surface modification (sm) mediated resistance against the 
phage DMS3vir. This showed that, sensitive bacteria had a significantly higher 
fitness when Baicalein was added to those competition experiments (U = 0, p < 
0.005) (Fig. 3A). In this experiment we are competing a completely phage-
sensitive strain (CRISPR-KO) against a fully resistant strain (sm). The resistant 
sm strain always has a higher fitness so the relative fitness of the sensitive cells 
does not exceed 1 (where a value of 1 indicates equal relative fitness). The 
addition of baicalein does increase the fitness of sensitive cells but does not 
provide complete immunity as sm resistance does. These data therefore confirm 
that Baicalein enhances phage resistance, hence lowering the efficacy of the 
phage. 
We speculated that the reduced phage adsorption rates of phage in the presence 
of Baicalein may also explain the high levels of CRISPR immunity and low levels 
of sm resistance that evolve under the highest phage exposure levels (Fig. 1). 
CRISPR immunity is associated with an infection-induced fitness cost, whereas 
sm is associated with a fixed cost (34). As a consequence, inhibition of QS and 
phage adsorption could lead to an enhanced fitness of CRISPR immune bacteria 
relative to surface mutants. Indeed, direct competition between a CRISPR 
immune clone (BIM2) and a bacterium with surface-based resistance (sm) 
revealed that the relative fitness of BIM2 increased in the presence of Baicalein 
(U = 0, p < 0.005), and was not affected by the addition of AIs (U = 17, p > 0.9) 
(Fig. 7B). Since both the sm strain and BIM2 possess complete immunity against 
the infecting phage their relative fitness is equal in the absence of QS 
manipulation, however when QS is inhibited the relative fitness of BIM2 increases 
to around 10 times that of the sm strain. This can likely be explained by the 
relative costs of CRISPR-Cas compared with sm mediated resistance: Because 
sm resistance requires a fixed cost the cells pay this cost regardless of the 
frequency of infection, however CRISPR-Cas carries a induced cost which is 
dependent on the frequency of infection (34), therefore the increase of fitness we 
see here indicates that fewer infections occur when QS in inhibited. 
Finally, given that CRISPR immune bacteria are less efficient in removing phage 
in the presence of Baicalein (Fig. 6), we hypothesized the outcome of direct 
competition between CRISPR immune bacteria and sensitive bacteria is likely to 
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be also affected by Baicalein. Direct competition between CRISPR immune 
bacteria and sensitive bacteria showed that while QS AIs had no significant 
impact on the relative fitness of the CRISPR immune bacteria (U = 11, p > 0.9), 
their relative fitness increased in the presence of Baicalein (U = 2, p < 0.05) (Fig. 
7C). BIM2 (the CRISPR immune bacteria) has a higher fitness compared with the 
sensitive CRISPR-KO in the absence of QS manipulation simply because BIM2 
possesses phage resistance and the CRISPR-KO does not. Therefore, we 
expect very high values of relative fitness for BIM2 in competition with the 
CRISPR-KO. This is exactly what we see and, in agreement with the other 
competition experiments, we see that the addition of a QS inhibitor increases the 





Figure 7. Inhibiting QS increases the fitness of P. aeruginosa in the presence of 
phage A) Relative fitness of sensitive CRISPR-KO strain with the phage resistant 
surface mutant (sm) B) Relative fitness of BIM2 competed with a phage resistant 
strain (sm) C) Relative fitness of BIM2 competed with a sensitive CRISPR-KO 
strain. Boxes show mean, minimum and maximum values, error bars show 95% 
confidence interval and points represent individual replicates, N = 6.  
Dotted line in panels B and C indicates the point at which competing strains are 
equally fit (when relative fitness = 1). This is not present in panel A due to the very 
low relative fitness of the CRISPR-KO when competed with sm. 
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Collectively, these data show that inhibition of QS using Baicalein reduces the 
rate of phage adsorption, which in turn significantly changes the way selection 




Being able to manipulate phage resistance evolution may have important clinical 
impact, since bacteria that remain phage sensitive or evolve CRISPR immunity 
are more likely to retain their virulence levels compared to bacteria that evolved 
surface-based resistance (133, 223, 224). In the experiments presented here we 
tested the idea that, because QS regulates CRISPR-Cas expression, chemical 
inhibition of QS might enhance the efficacy of phage-mediated killing of bacteria 
and steer evolution of phage resistance away from CRISPR immunity and 
towards surface-based resistance. Surprisingly, we found that Baicalein 
enhanced the fitness of sensitive and CRISPR immune bacteria relative to 
surface mutants and failed to reduce the evolution of CRISPR immunity. This is 
because QS also regulates expression of the T4P, which is used as a receptor 
by many Pseudomonas phages, including phage DMS3vir (158, 206–211). As a 
consequence, the rate of phage adsorption is reduced in the presence of 
Baicalein, which favours CRISPR immune bacteria over sm because of their 
induced and fixed costs of resistance, respectively (34). These findings are 
important in the context of phage therapy where the evolution of CRISPR 
immunity is undesirable, and show that QS inhibition may have unanticipated 
effects on the evolutionary outcome of bacteria-phage interactions. 
QS has been studied extensively in Vibrio harveyi and P. aeruginosa; in V. 
harveyi the QS regulators AphA and LuxR control 167, and 625 genes 
respectively, and they co-regulate a further 77 genes (225) and at least 616 
genes have been identified as being controlled by QS in P aeruginosa (226). QS 
systems have been shown to control expression of genes in accordance with both 
inter and intra specific densities and species specific QS molecules can induce 
changes in associated microorganisms (227–230), plants and eukaryotic cells 
(231, 232). Furthermore it has been shown that QS autoinducers influence 
symbiotic and pathogenic relationships between microbial, mammalian and plant 
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hosts (228–233). A family of QS compounds known as AI-2 (234) are synthesised 
by the LuxS enzyme (235). The LuxS gene is widespread throughout gram-
positive and gram-negative bacteria (235), which has led to the suggestion that 
AI-2 is a “universal communicator” influencing behaviour of multiple species of 
bacteria (236). The potential of QS systems to influence such diverse behaviours 
and interactions has been led to them being referred to as “master regulators”. 
This makes manipulating QS to our advantage even more complex with many 
variables to account for (237). The data presented here provide an insight into 
how QS manipulation affects P. aeruginosa evolution in the presence of phage. 
This information will help to inform further investigations into how and why QS 
systems function in the manner they do and serve to help in predicting outcomes 
of manipulating QS. This is beneficial in medical settings where the ability to 
control commonly QS controlled traits such as virulence would be highly 
desirable, particularly in a clinically relevant strain such as P. aeruginosa. 
QS systems most commonly control genes which underpin traits that confer 
fitness benefits when bacteria reach high densities. These include clinically 
important traits and group behaviours such as the expression of virulence 
determinants (238), toxin production (239), biofilm formation (240), and swarming 
motility (218). Both biofilm formation and swarming motility require T4P 
expression and the presence of high numbers of individual bacteria, hence 
explaining why T4P expression is commonly found to be controlled by QS (218, 
221). In general, however, selection would be expected to drive gene regulatory 
networks that lead to the downregulation of phage receptors at high bacterial 
densities, since phages spread most effectively when their host bacteria are 
present at high densities. Indeed, experimental work has demonstrated that 
Escherichia coli downregulates receptors used by its phages Lambda and Chi 
when it reaches high cell densities, due to QS-mediated regulation of these genes 
(217). A similar finding was made for Vibrio anguillarium, which was more 
resistant to infection by its phage KVP40 at high cell densities due to QS-
mediated downregulation of the phage receptor OmpK (216).  
Some phages and other mobile genetic elements have evolved mechanisms that 
allow them to obtain information about the availability of hosts in the environment. 
For example, some temperate phages carry QS receptors (229) that can bind the 
autoinducers produced by the host they infect (228). A prophage of Vibrio cholera 
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that carries the QS receptor VqmA uses the autoinducers produced by the host 
as a cue to induce when cell densities of the host are high (233). Other temperate 
phages encode their own QS systems, known as Arbitrium systems, and 
preferentially enter the prophage state once the signal concentration becomes 
high, presumably because this indicates that available hosts are running out 
(241). Likewise, some plasmids that infect Enterococcus faecalis encode sex 
pheromones that are involved in the regulation of horizontal spread of these 
plasmids (242). These examples highlight the importance of host cell density and 
signaling amongst hosts and their mobile genetic elements in shaping the 
epidemiology of parasitic DNA. 
Given that infection risk increases with cell density, it makes sense why CRISPR 
immune systems are positively regulated by QS (53, 195). At high cell densities 
it is important that hosts are able to target and remove non-adaptive MGEs that 
would otherwise spread rapidly through the population. However, whether or not 
these regulatory circuits can be leveraged in clinical settings will depend not only 
on regulation of CRISPR-Cas, but also on the way phenotypic phage resistance 
against MGEs is regulated. When phage receptors are negatively regulated by 
QS, as in the E. coli and V. anguillarium examples outlined above, QS inhibitors 
and phage may provide a synergistic efficacy. In the case of P. aeruginosa, the 
vast majority of phages characterized to date appear to either use LPS or the 
T4P as their receptor. This work shows that synergy is unlikely between pilus-
specific phages and QS inhibitors. However, whether there is synergy between 
Baicalein and LPS-specific phage remains an exciting possibility that needs to be 
examined experimentally in future studies. Future work should also consider the 
possibility that QS and CRISPR may interact differently under different 
conditions. For example recent findings that the evolution of CRISPR-Cas is 
influenced by local microbial communities (133), that QS is more important in the 
evolution of CRISPR-Cas at environmental temperatures (243), and that QS 
signals can have inter-species effects (228–233) highlight a need to consider the 
importance of QS and CRISPR-Cas evolution in environmental studies where 






In this thesis I present data which provides valuable insights into the evolutionary 
and ecological importance of CRISPR-Cas. Using a study system in which phage 
infection results in the evolution of either CRISPR-Cas resistance (associated 
with a constitutive fitness cost) or sm defence (associated with a fixed fitness 
cost), I investigate when one type of defence is favoured over another. The 
findings presented here may have implications in clinical, natural and industrial 
settings as well as informing further studies into the evolution and ecology of 
bacterial defence against phage and the evolutionary outcomes of bacteria-
phage interactions. 
 
Increasing within population CRISPR-Cas allele diversity decreases phage 
persistence and potential for local adaptation 
High within-population CRISPR-Cas allele diversity is often observed in natural 
systems, but it is unclear why this is important (34, 134–136). Using bacterial 
populations harbouring varying levels of CRISPR allele diversity I found that 
phage were less able to infect host populations possessing high levels of CRISPR 
allele diversity and that as CRISPR allele diversity increased, infecting phage 
populations were eradicated more quickly (35). This demonstrates that 
population level CRISPR-Cas allele diversity is an important factor in bacteria-
phage interactions, consistent with the idea of “herd immunity” whereby hosts are 
not resistant against all phage but sufficient resistance allele diversity exists at 
the population level to prevent viral epidemics (244). We also found that phage 
are less likely to become locally adapted to hosts when the host population 
possesses higher levels of CRISPR allele diversity (165). This could be due to 
the number of susceptible hosts decreasing as resistance allele diversity 
increases preventing sufficient replication of phage for the emergence of 
CRISPR-Cas escape mutants and ongoing co-evolution. This may help to explain 
why local adaptation is not commonly observed in natural systems (245, 246), 
although it is more common in systems where parasite migration is more frequent 
than host migration. In these scenarios the parasite population will likely be more 
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genetically diverse (246), which is predicted to reduce the benefit of CRISPR-Cas 
(137). 
 
Increasing within-population phage diversity decreases the frequency of 
CRISPR-Cas evolution 
Increasing within-population phage genetic diversity is predicted to increase the 
cost of CRISPR-Cas resistance through cost of spacer acquisition as a new 
spacer is required to provide immunity against each novel phage genotype 
encountered. If individual cells within the host population do not possess 
complete immunity they are sensitive to phage infection, allowing phage to 
replicate and diversify (137, 138). Phage isolated from natural populations are 
often found to be highly diverse (247–249), however many laboratory 
experiments use clonal phage populations. By evolving a population of phage 
with increased genetic diversity, I was able to investigate how genetic diversity 
within an infecting phage population affects the evolution of bacterial immune 
defence. In keeping with previous theoretical models and correlational studies 
(137–140), I found that bacteria infected with the evolved genetically diverse 
phage were more likely to evolve sm defence over CRISPR-Cas resistance. This 
is because sm defence protects the host against a range of phage genotypes as 
opposed to the genotype specific mechanism of CRISPR-Cas. I also found that 
hosts which had evolved CRISPR-Cas resistance against diverse phage 
populations were more likely to have acquired multiple spacers than those 
infected by clonal phage. Interestingly, despite a significant decrease in the 
proportion of the population which evolved CRISPR-Cas resistance in response 
to diverse phage, I found no difference in the total number of spacers gained at 
the population level, or the rate of phage extinction. This supports the previous 
finding that herd immunity can play an important role in the evolution of CRISPR-
Cas (244), and is likely an important factor under the conditions tested here. 
Theoretical models predict that there will be a point at which the population level 
herd immunity effect is no longer effective if the genetic diversity of infecting 
phage population increases (137). As well as providing insight into the evolution 
and ecology of phage defence systems in bacteria, these findings may be of 
relevance to phage therapy, a possible alternative treatment for bacterial 
infections whereby a dose of phage is administered to eradicate pathogenic 
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bacteria (42, 57). In such scenarios it is important that the administered cocktail 
is tailored to the specific infection, therefore diversity is an important variable to 
be considered both in the pathogen population and the phage cocktail.  
 
Inhibiting cell-cell communication can select for CRISPR-Cas evolution 
Recent findings that the cell-cell communication system known as Quorum 
Sensing (QS) can affect the expression of CRISPR-Cas has led to the suggestion 
that we may be able to manipulate the evolution of CRISPR-Cas via QS to 
enhance phage therapy cocktails (53, 195). Since CRISPR-Cas has the ability to 
eradicate phage, its presence in a bacterial population could reduce the efficacy 
of phage therapy treatments. In addition, bacteria which remain phage sensitive 
or evolve CRISPR-Cas are more likely to retain virulence traits than bacteria 
which evolve resistance via sm (133, 223, 224). Hence the ability to predict and 
manipulate bacterial response to phage infection could be a valuable tool in 
treating problematic clinical infections. In this chapter I presented the first data on 
the evolutionary outcome of QS inhibition on the evolution of CRISPR-Cas 
immunity. I found that under certain conditions QS inhibition may increase 
selection for CRISPR-Cas and infer a partial phage resistance to host cells. This 
would be highly problematic in the context of phage therapy given that these cells 
are less likely to be infected by phage and therefore are more likely to survive 
rounds of phage therapy treatment. My findings show that inhibiting QS interferes 
with expression of the Type IV Pilus (T4P), this pilus is required for many 
Pseudomonas phage to adsorb to their hosts (210, 250), and so these findings 
may be applicable to other bacteria-phage interactions in which the T4P is the 
site of phage adsorption. However, the effect of QS inhibition on the expression 
of other phage binding sites, such as LPS binding page, were not tested here and 
therefore it is possible that QS inhibition may increase LPS binding phage 
sensitivity in bacteria but specific research into such a system would be required 
to confirm this. These findings highlight the importance of understanding the 
evolutionary outcome of manipulating QS in microbes as QS is a complex system 
controlling many regulatory pathways, therefore any manipulation may result in 





Diversity varies greatly in nature but how and why genetic diversity is generated 
and maintained is often not known. In host-pathogen relationships we know that 
diversity is an important determinant of the outcome of interactions. For example, 
in the monoculture effect in agriculture where less diverse crops are associated 
with a higher risk of disease infection and spread (251). Or in animals with low 
genetic diversity (for example inbred or endangered animals (252, 253)) which 
are also associated with increased susceptibility to pathogen infection. By 
understanding the evolutionary drivers and outcomes of host-pathogen 
interactions, we are more able to understand natural environmental interactions 
as well as potentially manipulate evolution in these systems to our advantage. 
Studies looking at the role of genetic diversity in evolution have the potential to 
influence many fields of study including conservation, medicine, epidemiology 
and evolution/co-evolution studies. 
Genetic diversity, both standing and in-situ generated, is an important and 
frequently overlooked variable in bacteria-phage dynamics. CRISPR-Cas is an 
important resistance mechanism in host-pathogen interactions in nature. The 
specific targeting mechanism of CRISPR-Cas is known to drive rapid evolution of 
genetic diversity at the individual and population levels in both host and parasite 
species (35, 43, 165) compared to other known diversity generating mechanisms 
such as germline mutation and sexual reproduction. This is because CIRSPR-
Cas can generate variation within a generation (i.e. by acquiring a new spacer), 
whereas diversity generated through sexual reproduction can only be created 
between generations (i.e during recombination stage of meiosis) (254).  Bacteria 
carrying CRISPR-Cas systems are often associated with higher pathogenicity 
than other resistance mechanisms (133), so understanding the evolutionary 
drivers of CRISPR-Cas would allow us to predict and manipulate problematic 
pathogens carrying the system. Despite this we know relatively little about how 
and why CRISPR-Cas evolves and is maintained in nature. My experiments 
focusing on diversity show that within-population genetic diversity is an important 
factor in the evolution of bacterial immune defence and phage response with high 
CRISPR-Cas allele diversity associated with increased phage extinction, reduced 
local adaptation of phage, and therefore reduced likelihood of ongoing 
coevolution. Increased within-population phage diversity results in increasing 
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selection for generalist phage defence (sm) over specific phage defence 
(CRISPR-Cas).  
 
QS systems are thought to be widespread in nature (235) and are known to be 
master regulators, influencing the expression of a wide range of genes within 
species (225, 226), between different bacterial species (236), other 
microorganisms (227–230) and even plants and eukaryotic cells (231, 232). 
Furthermore it has been shown that QS autoinducers influence symbiotic and 
pathogenic relationships between microbial, mammalian and plant hosts (228–
233). This makes manipulating QS to our advantage incredibly complex with 
many variables to account for (237).  While QS manipulation is a potentially 
powerful tool for improving the efficacy of phage therapy treatments the data I 
present here indicate that the complexity of this system means manipulation may 
have undesirable secondary effects. Through the experiments presented I was 
able to determine that in the study system I used QS inhibition was interfering 
with production of the Type IV pilus, which is required for binding by the phage 
(158). Further research is required into the bacterial species commonly targeted 
by phage therapy and their phage in order to determine if QS inhibition may be 
more effective in different systems. It has recently been shown that CRISPR-Cas 
is more active at environmental temperatures compared with warmer 
temperatures such as when infecting hosts (243). Bacteria occupying colder 
environmental niches grow more slowly than those occupying warmer within-host 
niches. The slower growth rate provides more time for the expression of CRISPR-
Cas complexes within cells, increasing the chance of infecting phage being 
detected and destroyed by increasing the frequency of possible adaptation and 
interference events (243). This suggests that the link between QS and CRISPR-
Cas may be important at environmental temperatures and it has been suggested 
that under these conditions QS and CRISPR-Cas work synergistically to enhance 
CRISPR-Cas resistance (243). This may explain why I was unable to detect a 
direct effect of QS on CRISPR-Cas activity as these experiments were carried 
out at temperatures representative of within-host conditions. It is therefore 
possible that under environmental conditions the inhibition of QS would have 
stronger effects on the evolution of CRISPR-Cas. Future experiments should 
focus on how QS manipulation affects the evolution of CRISPR-Cas in 
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environmental conditions to add further insight into the link between these 
mechanisms. 
Studies which consider both the individual and group effects of evolution must be 
considered in order to gain a clear insight into the complexities of what drives and 
maintains CRISPR-Cas evolution. Experiments focusing on spatial structure may 
be of particular help when investigating the function and evolution of CRISPR-
Cas in environmental settings, spatial structure is predicted to be important in the 
evolutionary outcome of bacteria-phage interactions (79, 255) and this has been 
shown to be true for CRISPR-Cas systems (244, 256, 257). Furthermore 
structured environments such as biolfilms and soil have been found to be 
important environmental reservoirs for multi drug resistant human pathogens 
(258). Increasing spatial structure decreases mobility of both phage and bacteria, 
affecting both the frequency of bacteria-phage encounters and the likelihood of 
encountering novel genotypes (79, 244). My data show that CRISPR-Cas is 
favoured when phage genetic diversity is low, therefore in spatially structured 
environments both QS and phage diversity are likely to be important factors in 
CRISPR-Cas evolution. 
 
Applications of findings 
Any novel understanding or method of manipulation of CRISPR-Cas will help to 
inform studies investigating microbial systems where CRISPR-Cas is present as 
well as advancing our ability to utilise phage derived antimicrobial strategies or 
bio-technological tools. Phage based treatments have shown promise in the 
control the growth of Campylobacter and Salmonella on chicken skin (259), 
Salmonella enteritidis in cheese (260), Listeria monocytogenes on meat (261) 
and on fresh-cut fruit (262), and Salmonella also on fresh-cut fruit (262). In 
humans phage therapy has also shown promise, one study reports complete 
eradication of  a multi drug resistant strain of Acinetobacter baumannii after 
isolation and administration of infective phage (263) while another reports clinical 
improvement of a Mycobacterium abscessus infection following treatment with a 
cocktail of engineered phage (60) as well as several other promising trials (56–
60). In all applications of phage treatments it is vital that we have the necessary 
information to predict the evolutionary outcome of bacteria-phage interactions to 
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ensure efficacy of treatment and avoid inadvertently selecting for undesirable 
traits such as phage resistance and bacterial virulence, the findings presented 
here provide insight which may be of importance when predicting these 
interactions.  
In industrial processes where phage infection can result in product loss and 
therefore increased product price it has been suggested that bacteria may be 
engineered to possess CRISPR-Cas defence against invading phage. Indeed, 
the discovery that commercially successful dairy “starter strains” (bacteria which 
are added to milk to produce products such as yoghurt and cheese) of 
Streptococcus thermophilus possessed CRISPR-Cas resistance against 
common phage (109) has led to research focussing on engineering the CRISPR-
Cas systems of bacteria to further increase productivity and minimise product 
loss (66, 264). In addition to yoghurt and cheese production phage resistance via 
CRISPR-Cas would be applicable to many diverse industrial processes where 
microbial fermentations are vulnerable to infection. For example,  B. thuringiensis 
is a commonly used organic pesticide which is present in 90% of all pesticides 
sold globally (265) and, as in yoghurt and cheese production, vats are often lost 
to phage infections. If we can reduce the cost of production of B. thuringiensis 
pesticides the cost of producing organic crops will be reduced promoting the use 
of these products over more harmful, but currently less expensive pesticide 
products at the production level and reducing the price of organic products at the 
consumer level making organic food a more affordable choice. 
Overall, I hope that the findings presented here will help to inform and guide future 
research into microbial interactions, CRISPR-Cas evolution and may have 
applications in clinical, laboratory or field experiments working with microbial 
populations where CRISPR is present. Additionally, I hope that future clinical and 
industrial applications will consider these findings to help predict, manipulate and 
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